I

+ Studies in 2000-2009 List
* Studies in Pre-2000 List

IBS/IBD + (See Also BOWEL DISORDERS)
IBUPROFEN + (Blocks Breakdown of Anandamide which Actually Relieves Pain)
IDRASIL (‘Natural Phytocannabinoid’ Pill, Available in California by Dr Recommendation)
IMMUNE SYSTEM*+
IMMUNE THROMBOCYTOPENIA
INCONTINENCE (See BLADDER)
INDICATIONS AND CLINICAL USES*+
INFANTS (0 to 2 years) (See Also GERMINAL MATRIX HEMORRHAGE)
INFLAMMATION*
INFLUENZA (See FLU/INFLUENZA)
INJURIES (See WOUNDS AND INJURIES)
INTERACTIONS WITH OTHER DRUGS*+
ISAACS’ SYNDROME/ACQUIRED NEUROMYOTONIA +
IQ/MEMORY/COGNITIVE EFFECTS*+
ITCH (See PRURITIS)


IBS/IBD 
Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232190/?toolubmed
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease (full-2011) http://www.nature.com/mi/journal/v4/n5/full/mi201118a.html
A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents (full-2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2011.01742.x/full
Pharmacogenetic Trial of a Cannabinoid Agonist Shows Reduced Fasting Colonic Motility in Patients with Non-Constipated Irritable Bowel Syndrome (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202649/
Cannabis use amongst patients with inflammatory bowel disease (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21795981
Role of cannabinoid receptors and RAGE in inflammatory bowel disease (abst-2011) http://www.unboundmedicine.com/medline/ebm/record/21472688/abstract/Role_of_cannabinoid_receptors_and_RAGE_in_inflammatory_bowel_disease_
Cannabis Use Common Among Patients With Inflammatory Bowel Disease, Study Says (news-2011) http://norml.org/news/2011/08/04/cannabis-use-common-among-patients-with-inflammatory-boweldisease-study-says
top
Irritable bowel syndrome: a dysfunction of the endocannabinoid system? (full-2012) http://www.gastrojournal.org/article/S0016-5085%2811%2901710-0/fulltext
The Gastrointestinal Pharmacology of Cannabinoids: Focus on Motility (full-2012) http://content.karger.com/produktedb/produkte.asp?DOI=000339072&typdf
Genetic Epidemiology and Pharmacogenetics in Irritable Bowel Syndrome (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3362100/
Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome (full-2012) http://ajpgi.physiology.org/content/302/10/G1075
Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775711/
Gut microbiota and the development of obesity (full-2012) http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112012000500007&lng=en&nrm=iso&tlng=en
The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22917662?dopt=Abstract
Cannabidiol in Inflammatory Bowel Diseases: A Brief Overview (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22815234
The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22917662
Agents that act luminally to treat diarrhoea and constipation (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22945441
Cannabis Finds Its Way into Treatment of Crohn’s Disease (full-2013) http://www.karger.com/Article/Pdf/356512
Role of endogenous cannabinoid system in the gut (full-2013) http://www.actaps.com.cn/qikan/manage/wenzhang/2013-4-12.pdf
Irritable Bowel Syndrome and Migraine: Bystanders or Partners? (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714407/
Endocannabinoid and Cannabinoid-Like Fatty Acid Amide Levels Correlate with Pain-Related Symptoms in Patients with IBS-D and IBS-C: A Pilot Study (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874007/
Cannabinoid Receptor 1 Gene and Irritable Bowel Syndrome: Phenotype and Quantitative Traits (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602676/
Inhibition of p38/Mk2 signaling pathway improves the anti-inflammatory effect of WIN55 on mouse experimental colitis (full-2013) http://www.nature.com/labinvest/journal/v93/n3/full/labinvest2012177a.html
Industrial hemp decreases intestinal motility stronger than indian hemp in mice (link to PDF-2013) http://www.europeanreview.org/article/3266
Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23415610
Preventive and therapeutic oral administration of the pentacyclic triterpene α,β-amyrin ameliorates dextran sulfate sodium-induced colitis in mice: The relevance of cannabinoid system. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23454360
Cannabidiol in inflammatory bowel diseases: a brief overview. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/22815234
Interleukin 17A evoked mucosal damage is attenuated by cannabidiol and anandamide in a human colonic explant model. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24238999
Inhibition of fatty acid amide hydrolase (FAAH) as a novel therapeutic strategy in the treatment of pain and inflammatory diseases in the gastrointestinal tract (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24275607
top
Decreased Enteric Fatty Acid Amide Hydrolase Activity is Associated with Colonic Inertia in Slow Transit Constipation (abst – 2013) http://onlinelibrary.wiley.com/doi/10.1111/jgh.12346/abstract
Marijuana use patterns among patients with inflammatory bowel disease. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24185313
Still Believe Nature Got It Wrong? Top 10 Health Benefits of Marijuana (news – 2013) http://www.wakingtimes.com/2013/05/01/still-believe-nature-got-it-wrong-top-10-health-benefits-ofmarijuana/
Care and Feeding of the Endocannabinoid System: A Systematic Review of Potential Clinical Interventions that Upregulate the Endocannabinoid System (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951193/
Association of cannabinoid type 1 receptor and fatty acid amide hydrolase genetic polymorphisms in Chinese patients with irritable bowel syndrome (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24444427
Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid-like fatty acid amides. (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24460851
Switching cannabinoid response from CB2 agonists to FAAH inhibitors. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24508127
Toward modulation of the endocannabinoid system for treatment of gastrointestinal disease: FAAHster but not “higher”. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24641009
Vagal anandamide signaling via cannabinoid receptor 1 contributes to luminal 5-HT modulation of visceral nociception in rats. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24813296
Ultramicronized palmitoylethanolamide normalizes intestinal motility in a murine model of post-inflammatory accelerated transit: involvement of CB1 receptors and TRPV1. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24818658
The endocannabinoid anandamide regulates the peristaltic reflex by reducing neuroneuronal and neuro-muscular neurotransmission in ascending myenteric reflex pathways in rats. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24911079
Cannabis for inflammatory bowel disease. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24969296
Clinical endocannabinoid deficiency (CECD) revisited: Can this concept explain the therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24977967
Potential therapeutic applications of cannabinoids in gastrointestinal and liver diseases: Focus on Δ9-tetrahydrocannabinol pharmacology (abst-2014) http://onlinelibrary.wiley.com/doi/10.1002/9781118451281.ch7/summary
(Mo1121) Cannabinoid Use Decreases ED Utilization in a Gastroenterology Clinic Population (abst-2014)
http://www.gastrojournal.org/article/S0016-5085%2814%2962037-0/pdf
(Mo1122) Prevalence and Characterization of Cannabinoid Use in Patients With Gastrointestinal Disorders (abst-2014) http://www.gastrojournal.org/article/S0016-5085%2814%2962037-0/pdf
Palmitoylethanolamide, a naturally-occurring lipid, is an orally effective intestinal anti-inflammatory agent (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25205418
Medical Marijuana for Digestive Disorders: High Time to Prescribe? (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25199471
Cannabinoids Alleviate Experimentally Induced Intestinal Inflammation by Acting at Central and Peripheral Receptors (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25275313
N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N palmitoylethanolamine levels and counteracts murine colitis (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25384424
top
Identification of a highly potent and selective CB2 agonist, RQ-00202730, for the treatment of irritable bowel syndrome (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25499880
Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25531553
No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subjects (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25599774
A Gut Microbial Metabolite of Linoleic Acid, 10-Hydroxy-cis-12-octadecenoic Acid, Ameliorates Intestinal Epithelial Barrier Impairment Partially via GPR40-MEK-ERK Pathway (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25505251
AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally-restricted manner (abst-2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13069/abstract
No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subjects (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25599774
A Gut Microbial Metabolite of Linoleic Acid, 10-Hydroxy-cis-12-octadecenoic Acid, Ameliorates Intestinal Epithelial Barrier Impairment Partially via GPR40-MEK-ERK Pathway (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25505251
AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally-restricted manner (abst-2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13069/abstract
Pharmacogenetics in irritable bowel syndrome (full-2015) http://informahealthcare.com/doi/pdf/10.1517/17425255.2015.1048223
Monoglyceride lipase-deficiency causes desensitization of intestinal cannabinoid receptor type 1 and increased colonic μ-opioid receptor sensitivity. (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26075589
Cannabinoids Regulate Intestinal Motor Function and Electrophysiological Activity of  Myocytes in Rodents (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26254701
Cannabis Superior To Drugs For Inflammatory Bowel Condition (Crohn’s Disease) (news-2015) http://www.greenmedinfo.com/blog/cannabis-superior-drugs-inflammatory-bowel-condition-crohnsdisease


IBUPROFEN 
Cannabinoid system and cyclooxygenases inhibitors (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056416/
Scripps Research Scientists Discover Inflammation Is Controlled Differently in Brain and Other Tissues (news-2011) http://www.alphagalileo.org/ViewItem.aspx?ItemId=113766&CultureCode=en
Inhibitory properties of ibuprofen and its amide analogues towards the hydrolysis and cyclooxygenation of the endocannabinoid anandamide (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606911/
Inhibition of Endocannabinoid Metabolism by the Metabolites of Ibuprofen and Flurbiprofen (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4111603/
top


IDRASIL 
New Cannabis Pill On Track for 2012 Debut (news-2011) http://www.theweedblog.com/new-cannabis-pill-on-track-for-2012-debut/
A legit cannabis pill!? You don’t say! (news-2011) http://hailmaryjane.com/a-legit-cannabis-pill-you-dont-say/
Cannabis Effective for Easing MS Symptoms, but Not for Slowing Progression (news-2012) http://www.prweb.com/releases/-medical-marijuana/-information-san-francisc/prweb9568927.htm
European Medical Marijuana product Sativex is challenged by North America’s New Cannabis Pill Idrasil, Says Doobons (news/ad-2012) http://www.prweb.com/releases/-medical-marijuana/-information-san-francisc/prweb9525356.htm
Weaker Hemp Derivatives Can’t Compare to Full-Spectrum Marijuana Pills (news/ad- 2012) http://www.prweb.com/releases/marijuanapills/cannabispill/prweb10099535.htm


IMMUNE SYSTEM
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005548/?tool=pubmed
Cannabidiol attenuates delayed-type hypersensitivity reactions via suppressing T-cell and macrophage reactivity (full-2010) http://www.nature.com/aps/journal/v31/n12/full/aps2010155a.html
Do cannabinoids have a therapeutic role in transplantation? (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2923447/?tool=pubmed
Immunoregulation of a CB2 receptor agonist in a murine model of neuroAIDS (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109320/
Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties (full-2010) http://onlinelibrary.wiley.com/doi/10.1002/eji.201040667/full
Cannabinoids and Viral Infections (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903762/?tool=pmcentrez
Cannabinoids and the immune system: an overview (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20153077
Role of Myeloid-Derived Suppressor Cells in Amelioration of Experimental Autoimmune Hepatitis Following Activation of TRPV1 Receptors by Cannabidiol (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069975/?tool=pmcentrez
New blood brothers: the GPR55 and CB2 partnership (full-2011) http://www.nature.com/cr/journal/vaop/ncurrent/full/cr201177a.html
Commentary: Functional Neuronal CB2 Cannabinoid Receptors in the CNS. (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137183/?tool=pubmed
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura. (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232275/
Cannabinoid Receptor 2 Is Critical for the Homing and Retention of Marginal Zone B Lineage Cells and for Efficient T-Independent Immune Responses (full-2011) http://www.jimmunol.org/content/187/11/5720.full.pdf+html
Deletion of cannabinoid receptors 1 and 2 exacerbates APC function to increase inflammation and cellular immunity during influenza infection (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206470/
Cannabinoids and Innate Immunity: Taking a Toll on Neuroinflammation (link to PDF-2011) http://www.tswj.com/2011/230786/abs/
top
Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21626285
Immunomodulatory properties of kappa opioids and synthetic cannabinoids in HIV-1 neuropathogenesis (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21850403
Cannabis use and Cognitive Function: Eight Year Trajectory in a Young Adult Cohort (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21749524
Design and evaluation of a novel fluorescent CB2 ligand as probe for receptor visualization in immune cells (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21855337
Dynamic changes to the endocannabinoid system in models of chronic pain (full-2012) http://rstb.royalsocietypublishing.org/content/367/1607/3300.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
Cannabinoid 2 (CB2) Receptor Involvement in the Down-regulation but not Upregulation of Serum IgE Levels in Immunized Mice. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419805/
Tumor necrosis factor activation of vagal afferent terminal calcium is blocked by cannabinoids (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342927/
Cannabinoid Receptor 2 Signaling in Peripheral Immune Cells Modulates Disease Onset and Severity in Mouse Models of Huntington’s Disease (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753072/
Review article: Mast cell–glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481533/
Endocannabinoid modulation of jejunal afferent responses to LPS (full – 2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2012.01961.x/full
The endocannabinoid system: a revolving plate in neuro-immune interaction in health and disease. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22367605
Cannabinoid receptor-2-selective agonists improve recovery in experimental autoimmune encephalomyelitis (abst – 2012) http://www.jimmunol.org/cgi/content/meeting_abstract/188/1_MeetingAbstracts/116.7?maxtoshow=&hits=25&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=130&sortspec=date&resourcetype=HWCIT
Differential migratory properties of monocytes isolated from human subjects naïve and non-naïve to Cannabis. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22492174
Involvement of the endogenous cannabinoid 2 ligand 2-arachidonyl glycerol in allergic inflammation. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22652530
Novel compounds to activate cannabinoid receptors in immune system wins award for young Hebrew University researcher (news – 2012) http://www.alphagalileo.org/ViewItem.aspx?ItemId=120986&CultureCode=en
Δ9-tetrahydrocannabinol impairs the inflammatory response to influenza infection: role of antigen-presenting cells and the cannabinoid receptors 1 and 2. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551428/
Magnitude of stimulation dictates the cannabinoid-mediated differential T cell response to HIVgp120 (full – 2013) http://www.jleukbio.org/content/92/5/1093.full
Cannabinoid Receptor 2 Protects against Acute Experimental Sepsis in Mice (full-2013) http://www.hindawi.com/journals/mi/2013/741303/
top
Distinct microRNA expression profile and targeted biological pathways in functional myeloid-derived suppressor cells induced by Δ9-Tetrahydrocannabinol in vivo: Regulation of CCAAT/enhancer binding protein alpha by microRNA-690 (full-2013) http://www.jbc.org/content/early/2013/11/07/jbc.M113.503037.long
The cannabinoid receptor type 2 as mediator of mesenchymal stromal cell immunosuppressive properties (full-2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0080022
Cannabinoid Receptor 2 (CB2) Plays a Role in the Generation of Germinal Center and Memory B Cells, but Not in the Production of Antigen-Specific IgG and IgM, in Response to T-dependent Antigens (full-2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0067587
2-Arachidonoyl-glycerol- and arachidonic acid-stimulated neutrophils release antimicrobial effectors against E. coli, S. aureus, HSV-1, and RSV (full-2013) http://www.jleukbio.org/content/93/2/267.long
Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877544/
Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis. (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641032/
Δ9-tetrahydrocannabinol impairs the inflammatory response to influenza infection: role of antigen-presenting cells and the cannabinoid receptors 1 and 2 (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551428/
Multiple sclerosis and the blood-central nervous system barrier. (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3562587/
Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation. (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663904/
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors. (full-2013) http://www.sciencedirect.com/science/article/pii/S0969996113001939
Cannabinoid (CB)1 receptors are critical for the innate immune response to TLR4 stimulation (full-2013) http://ajpregu.physiology.org/content/305/3/R224
Targeting the Endocannabinoid System to Treat Sepsis (review-2013) http://www.signavitae.com/articles/review-articles/222-targeting-the-endocannabinoid-system-to-treatsepsis
Cannabinoid CB2 receptor gene (CNR2) polymorphism is associated with chronic childhood immune thrombocytopenia in Egypt. (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23406660
Cannabinoids Inhibit T-cells via Cannabinoid Receptor 2 in an In Vitro Assay for Graft Rejection, the Mixed Lymphocyte Reaction. (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23824763
Cannabinoid receptor modulation of the endothelial cell inflammatory response (abst-2013) http://www.jimmunol.org/cgi/content/meeting_abstract/190/1_MeetingAbstracts/112.29?sid=c3422dd2-7ad0-42e4-a862-845dc670f7cf
Intraperitoneal injection of -9-tetrahydrocannabinol induces local MDSCs with potent immunosuppressive properties (abst-2013) http://www.jimmunol.org/cgi/content/meeting_abstract/190/1_MeetingAbstracts/208.5?sid=c3422dd2-7ad0-42e4-a862-845dc670f7cf
Palmitoylethanolamide is a New Possible Pharmacological Treatment for the Inflammation Associated with Trauma (abst-2013) http://www.eurekaselect.com/106175/article
Neuroimmmune interactions of cannabinoids in neurogenesis: focus on interleukin-1β (IL-1β;) signalling (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24256257
top
South Carolina researchers find THC in pot could turn microRNA on or off (news – 2013) http://medcitynews.com/2013/11/south-carolina-researchers-find-thc-pot-turn-microrna/
Anandamide Attenuates Th-17 Cell-Mediated Delayed-Type Hypersensitivity Response by Triggering IL-10 Production and Consequent microRNA Induction (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974854/
Polyunsaturated Fatty Acid-Derived Lipid Mediators and T Cell Function (full-2014) http://www.ncbi.nlm.nih.gov/pubmed/24611066
Experimental cannabinoid 2 receptor-mediated immune modulation in sepsis (full-2014) http://www.hindawi.com/journals/mi/2014/978678/
The in vitro GcMAF effects on endocannabinoid system transcriptionomics, receptor formation, and cell activity of autism-derived macrophages (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996516/
The expression of cannabinoid receptor 1 is significantly increased in atopic patients (full-2014) http://www.jacionline.org/article/S0091-6749%2813%2902936-9/fulltext
Cannabidiol enhances microglial phagocytosis via transient receptor potential (TRP) channel activation (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24641282
Therapeutical Potential of CB2 Receptors in Immune-Related Diseases. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24720538
Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24742657
What we know and do not know about the cannabinoid receptor 2 (CB2) (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24877594
Role of Endocannabinoid Activation of Peripheral CB1 Receptors in the Regulation of Autoimmune Disease (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24911431
The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24644287
CANNABINOIDS INCREASE LUNG CANCER CELL LYSIS BY LYMPHOKINEACTIVATED KILLER CELLS VIA UPREGULATION OF ICAM-1 (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25069049
Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25135301
Inhaled medicinal cannabis and the immunocompromised patient (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25216851
Cannabinoid receptor type 2 activation in atherosclerosis and acute cardiovascular diseases (abst-2014) htp://www.ncbi.nlm.nih.gov/pubmed/25245379
Histone modifications are associated with Δ9-tetrahydrocannabinol-mediated alterations in antigen-specific T cell responses (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24841204
Cannabinoid receptor 1 but not 2 mediates macrophage phagocytosis by G(α)i/o/RhoA/ROCK signaling pathway (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25545473
Targeting cannabinoid receptor-2 pathway by phenylacetylamide suppresses the proliferation of human myeloma cells through mitotic dysregulation and cytoskeleton disruption (abst-2015) http://onlinelibrary.wiley.com/doi/10.1002/mc.22251/abstract
Endocannabinoid signaling in innate and adaptive immunity (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25585882
Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25601726
Endocannabinoid signaling in innate and adaptive immunity (abst-2015) http://onlinelibrary.wiley.com/doi/10.1111/imm.12441/abstract
top
The herbal-derived honokiol and magnolol enhances immune response to infection with methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant S. aureus (MRSA) (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25586586
Targeting cannabinoid receptor-2 pathway by phenylacetylamide suppresses the proliferation of human myeloma cells through mitotic dysregulation and cytoskeleton disruption (abst – 2015) http://onlinelibrary.wiley.com/doi/10.1002/mc.22251/abstract
Endocannabinoid signaling in innate and adaptive immunity (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25585882
Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25601726
Endocannabinoid signaling in innate and adaptive immunity (abst-2015) http://onlinelibrary.wiley.com/doi/10.1111/imm.12441/abstract
The herbal-derived honokiol and magnolol enhances immune response to infection with methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant S. aureus (MRSA) (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25586586
Possible Immunosuppressive Effects of Drug Exposure and Environmental and Nutritional Effects on Infection and Vaccination (full – 2015) http://www.hindawi.com/journals/mi/2015/349176/
Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function (full-2015) http://link.springer.com/article/10.1007/s11481-015-9615-z/fulltext.html
Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells. (full – 2015) http://onlinelibrary.wiley.com/doi/10.1111/apha.12474/full
Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells. (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363052/
Endocannabinoid signaling in innate and adaptive immunity. (full – 2015) http://onlinelibrary.wiley.com/doi/10.1111/imm.12441/full
Effects of Cannabinoids on T-cell Function and Resistance to Infection (full – 2015) http://tinyurl.com/oqjfy9j
Pathogenesis of Systemic Sclerosis. (full – 2015) http://journal.frontiersin.org/article/10.3389/fimmu.2015.00272/full
Differential immune mechanism to HIV-1 Tat variants and its regulation by AEA (full – 2015) http://www.nature.com/srep/2015/150505/srep09887/full/srep09887.html
Elevated Levels of Endocannabinoids in Chronic Hepatitis C May Modulate Cellular Immune Response and Hepatic Stellate Cell Activation. (link to PDF-2015) http://www.mdpi.com/1422-0067/16/4/7057
Targeting cannabinoid receptor-2 pathway by phenylacetylamide suppresses the proliferation of human myeloma cells through mitotic dysregulation and cytoskeleton disruption (abst – 2015) http://onlinelibrary.wiley.com/doi/10.1002/mc.22251/abstract
Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25601726
The herbal-derived honokiol and magnolol enhances immune response to infection with methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant S. aureus (MRSA). (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25586586
The cannabinoid receptor 2 is involved in acute rejection of cardiac allografts (abst – 2015) http://www.sciencedirect.com/science/article/pii/S0024320515001290
Δ9 Tetrahydrocannabinol-mediated epigenetic modifications elicit myeloid-derived cell activation via STAT3/S100A8. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25713087
top
For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disorders. (abst – 2015) http://www.sciencedirect.com/science/article/pii/S027858461500055X
The endocannabinoid system and its therapeutic implications in rheumatoid arthritis (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25791728
Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoylglycerol and arachidonoyl-ethanolamide, and their metabolites. (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25877930
Modulation of HIVGP120 Antigen-Specific Immune Responses In Vivo by Δ9-Tetrahydrocannabinol (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25900076
Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25917103
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25935384
Downstream effects of endocannabinoid on blood cells: implications for health and disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25957591
Δ9-Tetrahydrocannabinol attenuates allogeneic host-versus-graft response and delays skin graft rejection through activation of cannabinoid receptor 1 and induction of myeloid-derived suppressor cells (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26034207


IMMUNE THROMBOCYTOPENIA
Immune thrombocytopenia in children and adults: what’s the same, what’s different? (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232253/
CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232275/
Childhood immune thrombocytopenia-who will spontaneously recover? (full–2013) http://www.seminhematol.org/article/S0037-1963%2813%2900032-2/fulltext
Cannabinoid CB2 receptor gene (CNR2) polymorphism is associated with chronic childhood immune thrombocytopenia in Egypt (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23406660
Synthetic marijuana “K2” induced ITP (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24749892


INDICATIONS AND CLINICAL USES

Information for Health Care Professionals- Marihuana (marijuana, cannabis) dried plant for administration by ingestion or other means (Health Canada) (full-2010) http://www.hc-sc.gc.ca/dhp-mps/marihuana/med/infoprof-eng.php
“Who Are Medical Marijuana Patients? Population Characteristics from Nine California Assessment Clinics” (abst+news-2010) http://blog.norml.org/2011/07/21/who-are-americas-medical-marijuana-patients/
Cannabis Rx: Cutting Through the Misinformation : Dr. Andrew Weil (news – 2010) http://www.huffingtonpost.com/andrew-weil-md/can-cannabis-treat-cancer_b_701005.html
top
Cannabis and Its Derivatives: Review of Medical Use (full – 2011) http://www.jabfm.org/cgi/content/full/24/4/452
An Analysis of Applicants Presenting to a Medical Marijuana Specialty Practice in California (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3673028/
Medical cannabis: the opportunity versus the temptation (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/22352284
Marijuana (Cannabis sativa) Mayo Clinic (news-2011) http://www.mayoclinic.com/health/marijuana/NS_patient-marijuana/DSECTION=evidence
CBD Tops The Chart (news-2011) http://morganlesko.com/cbd/2011/12/23/cbd-tops-the-chart/
Medical Reasons for Marijuana (news – 2011) http://www.livestrong.com/article/98476-medical-reasons-marijuana/
Patients Substitute Marijuana for Prescription Drugs (news-2011) http://www.internalmedicinenews.com/news/more-top-news/single-view/patients-substitute-marijuana-forprescription-drugs/e5e5aebf50.html
Medical Marijuana: Clearing Away the Smoke (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358713/
Therapeutic Potentials and uses of Cannabinoid Agonists in Health and Disease Conditions (full – 2012) http://maxwellsci.com/print/bjpt/v3-76-88.pdf
The Therapeutic Potential of Cannabis and Cannabinoids (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442177/
Marijuana: modern medical chimaera. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22873011
Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/23103355
Cannabis Strain Explorer (web page – 2012) http://www.leafly.com/explore
Therapeutic potential of cannabinoid medicines. (full – 2013) http://onlinelibrary.wiley.com/doi/10.1002/dta.1529/full
The pharmacologic and clinical effects of medical cannabis. (full – 2013) http://onlinelibrary.wiley.com/doi/10.1002/phar.1187/full
The prevalence and incidence of medicinal cannabis on prescription in The Netherlands. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23588562
Cannabis for therapeutic purposes: Patient characteristics, access, and reasons for use. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24095000
Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23291209
As Anecdotal Reports of Anti-Cancer Effects from Cannabis ‘Oil’ Pile Up, Doctors Stress Need to Document Its Effects (news – 2013) http://www.alternet.org/drugs/anecdotal-reports-anti-cancer-effects-cannabis-oil-pile-doctors-stress-needdocument-its
Still Believe Nature Got It Wrong? Top 10 Health Benefits of Marijuana (news – 2013) http://www.wakingtimes.com/2013/05/01/still-believe-nature-got-it-wrong-top-10-health-benefits-ofmarijuana/
Therapeutic benefits of cannabis: a patient survey. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998228/
The Comprehensive Report on the Cannabis Extract Movement and the Use of Cannabis Extracts to Treat Diseases (report–2014) http://www.slideshare.net/TheHempSolution/comprehensive-report-on-the-cannabis-extract-movement
Therapeutic Satisfaction and Subjective Effects of Different Strains of Pharmaceutical-Grade Cannabis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24747979
top
(Mo1122) Prevalence and Characterization of Cannabinoid Use in Patients With Gastrointestinal Disorders (abst–2014) http://www.gastrojournal.org/article/S0016-5085%2814%2962037-0/pdf
Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25191852
Medical marijuana: more questions than answers (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25226202
Cannabinoid Breakdown (news–2014) http://www.bloomwellbend.com/cannabinoid-breakdown/
DR ALLAN FRANKEL’S EARLY VERSION INITIAL DOSAGE AND ADMINISTRATION GUIDE (news–2014) http://www.greenbridgemed.com/dr-allan-frankels-early-version-initial-dosage-and-administration-guide/
Medical marijuana: review of the science and implications for developmental-behavioral pediatric practice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25650954
What ailments does medical marijuana help? (news–2015) http://www.mnn.com/health/fitness-well-being/stories/what-ailments-does-medical-marijuana-help


INFANTS
Use of dronabinol (delta-9-THC) in autism: A prospective single-case-study with an early infantile autistic child (full–2010) http://www.cannabis-med.org/data/pdf/en_2010_04_1.pdf
Cannabinoid modulation of mother-infant interaction: is it just about milk? (abst–2012) http://www.degruyter.com/abstract/j/revneuro.2012.23.issue-5-6/revneuro-2012-0074/revneuro-2012-0074.xml?rskey=wRYgJd&result=1&q=cannabinoid
Cannnabinoids, Breast Milk, and Development (news – 2012) http://www.examiner.com/article/cannnabinoids-breast-milk-and-development
The Maternal Lifestyle Study: Sleep Problems in Children with Prenatal Substance Exposure (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917192/?tool=pubmed
The cannabinoid WIN55212-2 promotes neural repair after neonatal hypoxia-ischemia (full-2010) http://stroke.ahajournals.org/content/41/12/2956.long
Pregnant Women Smoking Pot Could Reduce Infant Mortality (news-2010) http://www.opposingviews.com/i/pregnant-women-smoking-pot-could-reduce-infant-mortality
CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232275/
Examining the Health and Drug Exposures among Canadian Children Residing in DrugProducing Homes (abst–2011) http://www.jpeds.com/article/S0022-3476%2811%2900522-1/abstract
Prolonged coma in a child due to hashish ingestion with quantitation of THC metabolites in urine (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/20634020/abstract/Prolonged_coma_in_a_child_due_to_hashish_ingestion_with_quantitation_of_THC_metabolites_in_urine_
What An Expectant Mother Eats Affects Children’s Psychology in Later Life (news–2011) http://nanopatentsandinnovations.blogspot.com/2011/01/what-expectant-mother-eats-affects.html
top
Cocaine, Opiate, and Cannabinoid Infant Mortality Study (news-2011) http://www.theweedstreetjournal.com/cocaine-opiate-cannabinoid-infant-mortality-study/
Unresolved Discrepancies between Cannabinoid Test Results for Infant Urine (full-2012) http://www.clinchem.org/content/58/9/1364.full
Acute cannabis poisoning in a 10-month-old infant (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22652516
Cannabis For Infant’s Brain Tumor, Doctor Calls Child “A Miracle Baby” (news-2012) http://www.huffingtonpost.com/2012/12/01/cannabis-for-infants-brai_n_2224898.html
Strange Reason for Baby’s Positive Pot Test Found (news-2012) http://ca.news.yahoo.com/strange-reason-babys-positive-pot-test-found-120630522.html
Cannnabinoids, Breast Milk, and Development (news-2012) http://www.examiner.com/article/cannnabinoids-breast-milk-and-development
Montreal hospital changes drug-testing protocol after baby’s seizure (news-2013) http://www.cbc.ca/news/canada/montreal/story/2013/05/15/montreal-villeneuve-kaia-false-positive-muhcroyal-victoria-acid-reflux.html?cmp=rss
Parents of epileptic N.J. tot lament medical marijuana delays (news-2013) http://articles.philly.com/2013-06-24/news/40148313_1_marijuana-law-marijuana-card-dispensary
Toronto family hopes for access to controversial treatment to cure baby’s rare epilepsy (news-2013) http://globalnews.ca/news/714104/toronto-family-hopes-for-access-to-controversial-treatment-to-curebabys-rare-epilepsy/
The consequences of pain in early life: injury-induced plasticity in developing pain pathways (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264936/
Meconium Drug Testing in Multiple Births in the USA (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24927721
Contribution of in utero drug exposure when interpreting hair results in young children (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25450508
New horizons for newborn brain protection: enhancing endogenous neuroprotection (full-2015) http://fn.bmj.com/content/early/2015/06/10/archdischild-2014-306284.long
A cannabinoid-intoxicated child treated with dexmedetomidine: a case report (full-2015) http://www.jmedicalcasereports.com/content/9/1/152
Use of paracetamol during pregnancy and child neurological development (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25851072
Association between paracetamol use in infancy or childhood with body mass index (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25864407
Pure cannabidiol in the treatment of malignant migrating partial seizures in infancy: a case report (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25882081
Endocannabinoid Levels in Newborns in Relation to the Mode of Delivery (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25915139
Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25960036
Cannabinoid receptor 2 attenuates microglial accumulation and brain injury following germinal matrix hemorrhage via ERK dephosphorylation in vivo and in vitro (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25963415
Retrospective Analysis of Tetrahydrocannabinol Based on 31 Neurologically Critically Ill Children (abst-2015) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1550707
Maternal marijuana use and neonatal morbidity (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26026918
top


INFLAMMATION
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005548/?tool=pubmed
Cannabinoids and Viral Infections (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903762/?tool=pmcentrez
European Patent Application EP2044935- A composition containing non-psychotropic cannabinoids for the treatment of inflammatory diseases (full-2010) http://www.freepatentsonline.com/EP2044935A1.html
The endocannabinoid system as a target for the treatment of neurodegenerative disease (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931550/?tool=pubmed
The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931570/?tool=pubmed
Regulatory Role of Cannabinoid Receptor 1 in Stress-Induced Excitotoxicity and Neuroinflammation (full-2010) http://www.nature.com/npp/journal/vaop/ncurrent/full/npp2010214a.html
Synthesis of Novel Cannabinoid Ligands and Their Use as Anti-Glioma and Anti Inflammatory Agents (full-2010) http://etd.uthsc.edu/WORLD-ACCESS/Gurley/2010-030-Gurley.pdf
Anti-inflammatory effects of the neurotransmitter agonist Honokiol in a mouse model of allergic asthma (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3197781/
N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor (full-2010) http://www.biomedcentral.com/1471-2202/11/44
Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936031/?tool=pubmed
Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone (SAB378), a peripherally restricted cannabinoid CB1/CB2 receptor agonist, inhibits gastrointestinal motility but has no effect on experimental colitis in mice (full-2010) http://jpet.aspetjournals.org/content/334/3/973.long
WIN55212-2 ameliorates atherosclerosis associated with suppression of pro inflammatory responses in ApoE-knockout mice (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20868672
Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: Role of CB(1)/CB(2) receptors (abst-2010) http://www.unboundmedicine.com/medline/ebm/record/21056512/abstract/Beneficial_effects_of_cannabinoids__CB__in_a_murine_model_of_allergen_induced_airway_inflammation:_Role_of_CB_1_/CB_2__receptors_
Levels of endocannabinoids and palmitoylethanolamide and their pharmacological manipulation in chronic granulomatous inflammation in rats (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/19931394
Light Marijuana Use Appears Protective Against Diabetes (news-2010) http://www.clinicalpsychiatrynews.com/index.php?id=2407&cHash=071010&tx_ttnews[tt_news]=41212
Hemp Oil Benefits for Skin (news-2010) http://www.livestrong.com/article/137621-hemp-oil-benefits-skin/
Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034694/?tool=pmcentrez
Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230631/?tool=pubmed
top
Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa (full-2011) https://www.jstage.jst.go.jp/article/bpb/34/5/34_5_774/_pdf
Gut feelings about the endocannabinoid system (full – 2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2011.01689.x/full
Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232190/?tool=pubmed
Local activation of cannabinoid CB1 receptors in the urinary bladder reduces the inflammation-induced sensitization of bladder afferents (full-2011) http://www.molecularpain.com/content/pdf/1744-8069-7-31.pdf
Cannabinoid CB2 Receptors Contribute to Upregulation of β-endorphin in Inflamed Skin Tissues by Electroacupuncture (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281798/
Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and cell death (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3081988/
The Antinociceptive Effects of JWH-015 in Chronic Inflammatory Pain Are Produced by Nitric Oxide-cGMP-PKG-KATP Pathway Activation Mediated by Opioids (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198780/?tool=pubmed
Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation (full – 2011) http://www.fasebj.org/content/25/8/2711.long
Cannabinoid Receptor Type 1 Protects Nigrostriatal Dopaminergic Neurons against MPTP Neurotoxicity by Inhibiting Microglial Activation (full-2011) http://www.jimmunol.org/content/187/12/6508.full?sid=c3422dd2-7ad0-42e4-a862-845dc670f7cf
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165957/pdf/bph0163-1479.pdf
Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ(9) -tetrahydrocannabinol in BV-2 microglial cells (full-2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01461.x/pdf
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085542/
Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3081988/pdf/nihms278422.pdf
GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132458/pdf/cr201160a.pdf
Resolution of inflammation by N-arachidonoylglycine (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196844/
Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ (full-2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01444.x/full
Deletion of cannabinoid receptors 1 and 2 exacerbates APC function to increase inflammation and cellular immunity during influenza infection (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206470/
US Patent 7884133 B2 Cannabidiol derivatives such as 3-(2,6-dihydroxy-4-pentylphenyl)-4-prop-1-en-2-ylcyclohexene-1-carboxylic acid, used as as analgesics, antiinflammatory and antidiarrheal agents (full-2011) https://www.google.com/patents/US7884133?dq=patent+7884133&hl=en&sa=X&ei=Ujb0U_6EEIW5ogSl84LYDg&ved=0CB4Q6AEwAA
top
Cannabinoids and Innate Immunity: Taking a Toll on Neuroinflammation (link to PDF-2011) http://www.tswj.com/2011/230786/abs/
Immunomodulatory properties of kappa opioids and synthetic cannabinoids in HIV-1 neuropathogenesis (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21850403
A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells (abst-2011) http://www.unboundmedicine.com/medline/ebm/record/21492165/abstract/A_synthetic_cannabinoid_CP55
940_inhibits_lipopolysaccharide_induced_cytokine_mRNA_expression_in_a_cannabinoid_receptor_independent_mechanism_in_rat_cerebellar_granule_cells_
The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21310228
Scripps Research Scientists Discover Inflammation Is Controlled Differently in Brain and Other Tissues (news–2011) http://www.alphagalileo.org/ViewItem.aspx?ItemId=113766&CultureCode=en
New metabolic pathway for controlling brain inflammation (news–2011) http://www.news-medical.net/news/20111021/New-metabolic-pathway-for-controlling-brain-inflammation.aspx
Prolonged oral Cannabinoid Administration prevents Neuroinflammation, lowers beta-amyloid Levels and improves Cognitive Performance in Tg APP 2576 Mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292807/
A Dysregulated Endocannabinoid-Eicosanoid Network Supports Pathogenesis in a Mouse Model of Alzheimer’s Disease (full–2012) http://download.cell.com/cell-reports/mmcs/journals/2211-1247/PIIS2211124712001258.mmc2.pdf
The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation (full–2012) http://www.jneuroinflammation.com/content/9/1/79
Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Noninflammatory Pain (full-2012) http://jpet.aspetjournals.org/content/338/1/114.full
The synthetic cannabinoid R(+)WIN55,212-2 augments interferon-β expression via peroxisome proliferator-activated receptor-α (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3408184/
Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuroinflammation, amyloidogenesis and memory impairment via inhibition of nuclear factor-kappaB in vitro and in vivo models (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323460/
N-acyl amines of docosahexaenoic acid and other n-3 polyunsatured fatty acids – From fishy endocannabinoids to potential leads (full-2012) http://onlinelibrary.wiley.com/doi/10.1111/bph.12030/full
Can the benefits of cannabinoid receptor stimulation on neuroinflammation, neurogenesis and memory during normal aging be useful in AD prevention? (full-2012) http://www.jneuroinflammation.com/content/9/1/10
Update on the role of cannabinoid receptors after ischemic stroke (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337695/?toolubmed
Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388241/
Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315437/?toolubmed
top
The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation (full-2012) http://www.jneuroinflammation.com/content/9/1/79
Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738192/
Cannabinoid modulation of neuroinflammatory disorders (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386505/
Targeting Fatty Acid Binding Protein (FABP) Anandamide Transporters – A Novel Strategy for Development of Anti-Inflammatory and Anti-Nociceptive Drugs (full-2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0050968
Fish oil and inflammatory status alter the n-3 to n-6 balance of the endocannabinoid and oxylipin metabolomes in mouse plasma and tissues (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483099/
Review article: The endocannabinoid system in normal and pathological brain ageing (full-2012) http://rstb.royalsocietypublishing.org/content/367/1607/3326.full?sid=161e7b36-5055-448b-962e-697c782e901d
Dietary linoleic acid elevates endogenous 2-arachidonoylglycerol and anandamide in Atlantic salmon (Salmo salar L.) and mice, and induces weight gain and inflammation in mice (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548985/
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579248/
β−Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB1 or CB2 receptors (full – 2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.01889.x/pdf
The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423256/
Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A(2A) receptor (full – 2012) http://www.sciencedirect.com/science/article/pii/S0014299912000052
Differential Modulation by Delta(9)-Tetrahydrocannabinol (∆ (9)-THC) of CD40 Ligand (CD40L) Expression in Activated Mouse Splenic CD4(+) T cells (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657729/
Effects of palmitoylethanolamide on intestinal injury and inflammation caused by ischemia-reperfusion in mice (full – 2012) http://www.jleukbio.org/content/91/6/911.full
Methylhonokiol attenuates neuroinflammation: a role for cannabinoid receptors? (full – 2012) http://www.jneuroinflammation.com/content/9/1/135
Activation of Cannabinoid Receptor 2 reduces inflammation in acute experimental pancreatitis via intra-acinar activation of p38 and MK2-dependent mechanisms (full – 2012) http://ajpgi.physiology.org/content/304/2/G181
Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632657/
Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371734/
Cannabinoids inhibit peptidoglycan-induced phosphorylation of NF-κB and cell growth in U87MG human malignant glioma cells (full–2012) http://www.spandidospublications.com/or/28/4/1176;jsessionid=52ED17697BFDC92E6F5F848306023474?text=fulltext
top
Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3325902/
Review article: Mast cell–glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481533/
Signaling through cannabinoid receptor 2 suppresses murine dendritic cell migration by inhibiting matrix metalloproteinase 9 expression (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488886/
DAGLβ inhibition perturbs a lipid network involved in macrophage inflammatory responses (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513945/
Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis (full–2012) http://www.sciencedirect.com/science/article/pii/S0014299912008485
4-O-methylhonokiol prevents memory impairment in the Tg2576 transgenic mice model of Alzheimer’s disease via regulation of β-secretase activity (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22330831?dopt=Abstract&holding=f1000,f1000m,isrctn
Endocannabinoids limit excessive mast cell maturation and activation in human skin (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22226549
The endocannabinoid system: a revolving plate in neuro-immune interaction in health and disease (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22367605
Cannabinoid signalling regulates inflammation and energy balance: The importance of the brain-gut axis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22269477
The Role of Cannabinoids In Inflammatory Modulation of Allergic Respiratory Disorders, Inflammatory Pain and Ischemic Stroke (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22420307
WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22634229
Differential migratory properties of monocytes isolated from human subjects naïve and non-naïve to Cannabis (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22492174
Cannabinoid receptor-2-selective agonists improve recovery in experimental autoimmune encephalomyelitis (abst – 2012) http://www.jimmunol.org/cgi/content/meeting_abstract/188/1_MeetingAbstracts/116.7?maxtoshow=&hits=25&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=130&sortspec=date&resourcetype=HWCIT
Cannabidiol affects the expression of genes involved in zinc homeostasis in BV-2 microglial cells (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22178458
Anti-Inflammatory Effect of the Endocannabinoid Anandamide in Experimental Periodontitis and Stress in the Rat (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22777139
Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22697514
Endocannabinoids alleviate proinflammatory conditions by modulating innate immune response in muller glia during inflammation (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22807196
Cannabidiol treatment ameliorates ischemia/reperfusion renal injury in rats (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22877651
top
A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22903455
A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22971837
N-arachidonoyl glycine induces macrophage apoptosis via GPR18 (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22266325
Anti-Inflammatory Effect of the Endocannabinoid Anandamide in Experimental Periodontitis and Stress in the Rat (abst–2012) http://content.karger.com/produktedb/produkte.asp?doi=339113
Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22697514?dopt=Abstract
Metamizol, a non-opioid analgesic, acts via endocannabinoids in the PAG-RVM axis during inflammation in rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22337336
CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation (abst–2012) http://onlinelibrary.wiley.com/doi/10.1002/glia.22366/abstract
Neuroprotective agents: cannabinoids (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/21420365
Update on the endocannabinoid-mediated regulation of gelatinase release in arterial wall physiology and atherosclerotic pathophysiology (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/23253273
Electroacupuncture reduces the expression of proinflammatory cytokines in inflamed skin tissues through activation of cannabinoid CB2 receptors (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22337285
Scientists find a new pharmacological target to modulate the effect of cannabinoids through their CB1 receptors (news–2012) http://www.alphagalileo.org/ViewItem.aspx?ItemId=122183&CultureCode=en
Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma (full–2013) http://www.jneuroinflammation.com/content/10/1/20
The cannabinoid receptor type 2 as mediator of mesenchymal stromal cell immunosuppressive properties (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0080022
The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632250/
Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation (full– 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663904/
Monoacylglycerol Lipase (MAGL) Inhibition Attenuates Acute Lung Injury in Mice (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808422/
The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717616/
The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain (full–2013) http://www.europeanneuropsychopharmacology.com/article/S0924-977X%2813%2900302-7/fulltext
The Dual Effect of Cannabinoid Receptor-1 Deficiency on the Murine Postoperative Ileus (full – 2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0067427
top
Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice (full – 2013) http://arthritis-research.com/content/15/6/R192
The Influence of Cannabinoids on Generic Traits of Neurodegeneration (full – 2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12492/full
A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury (full – 2013) http://www.jneuroinflammation.com/content/10/1/91
Implication of the anti-inflammatory bioactive lipid prostaglandin D2-glycerol ester in the control of macrophage activation and inflammation by ABHD6 (full – 2013) http://www.pnas.org/content/110/43/17558.long
Selective Activation of Cannabinoid Receptor 2 in Leukocytes Suppresses Their Engagement of the Brain Endothelium and Protects the Blood-Brain Barrier (full – 2013) http://ajp.amjpathol.org/article/S0002-9440%2813%2900557-9/fulltext
Cannabinoid receptor 2 suppresses leukocyte inflammatory migration by modulating the JNK/c-Jun/Alox5 pathway (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3650391/
Cannabinoid 1 Receptors in Keratinocytes Modulate Proinflammatory Chemokine Secretion and Attenuate Contact Allergic Inflammation (full – 2013) http://www.jimmunol.org/content/190/10/4929.long
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors (full – 2013) http://www.sciencedirect.com/science/article/pii/S0969996113001939
Inhibition of p38/Mk2 signaling pathway improves the anti-inflammatory effect of WIN55 on mouse experimental colitis. (full – 2013) http://www.nature.com/labinvest/journal/v93/n3/full/labinvest2012177a.html
Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641032/
Palmitoylethanolamide Reduces Formalin-Induced Neuropathic-Like Behaviour Through Spinal Glial/Microglial Phenotypical Changes in Mice (link to PDF–2013) http://www.eurekaselect.com/107975/article
Neuroglial Roots of Neurodegenerative Diseases: Therapeutic Potential of Palmitoylethanolamide in Models of Alzheimer’s Disease (link to PDF–2013) http://www.eurekaselect.com/107977/article
New Insights in Mast Cell Modulation by Palmitoylethanolamide (link to PDF – 2013) http://www.eurekaselect.com/107979/article
The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23296873
Inhibition of endocannabinoid degradation in experimental endotoxemia reduces leukocyte adhesion and improves capillary perfusion in the gut (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23382309
Preventive and therapeutic oral administration of the pentacyclic triterpene α,β-amyrin ameliorates dextran sulfate sodium-induced colitis in mice: The relevance of cannabinoid system (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23454360
Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23518609
Endocannabinoids: A unique opportunity to develop multitarget analgesics (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23623250
Glia and Mast Cells as Targets for Palmitoylethanolamide, an Anti-inflammatory and Neuroprotective Lipid Mediator (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23813098
Cannabinoid receptor modulation of the endothelial cell inflammatory response (abst – 2013) http://www.jimmunol.org/cgi/content/meeting_abstract/190/1_MeetingAbstracts/112.29?sid=c3422dd2 -7ad0-42e4-a862-845dc670f7cf
top
Cannabinoid CB2 receptors as novel target for inhibiting house dust mite induced allergic airway inflammation (abst – 2013) http://www.jimmunol.org/cgi/content/meeting_abstract/190/1_MeetingAbstracts/120.12?sid=c3422dd2-7ad0-42e4-a862-845dc670f7cf
Palmitoylethanolamide is a New Possible Pharmacological Treatment for the Inflammation Associated with Trauma (abst – 2013) http://www.eurekaselect.com/106175/article
Amyotrophic Lateral Sclerosis Treatment with Ultramicronized Palmitoylethanolamide: A Case Report (abst – 2013) http://www.eurekaselect.com/105507/article
CB1 Cannabinoid Receptor Agonist Prevents NGF-Induced Sensitization of TRPV1 in Sensory Neurons (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23850608
3-Carboxamido-5-aryl-isoxazoles as new CB2 agonists for the treatment of colitis (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23849204
CB1 and CB2 contribute to antinociceptive and anti-inflammatory effects of electroacupuncture on experimental arthritis of the rat temporomandibular joint (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23181276
Cannabinoids Decrease the Th17 Inflammatory Autoimmune Phenotype (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23892791
Controlling 2-arachidonoylglycerol metabolism as an anti-inflammatory strategy (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23891880
Anti-inflammatory activity of topical THC in DNFB-mediated mouse allergic contact dermatitis independent of CB1 and CB2 receptors (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23889474
Prospects for cannabinoid therapies in viral encephalitis (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24021420
Cannabidiol in inflammatory bowel diseases: a brief overview (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/22815234
Long-term supplementation of honokiol and magnolol ameliorates body fat accumulation, insulin resistance, and adipose inflammation in high-fat fed mice (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23901038
Anti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/22850623
Magnolol inhibits LPS-induced inflammatory response in uterine epithelial cells : magnolol inhibits LPS-induced inflammatory response (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23515857
Inhibition of fatty acid amide hydrolase (FAAH) as a novel therapeutic strategy in the treatment of pain and inflammatory diseases in the gastrointestinal tract (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24275607
Mitochondrial JNK phosphorylation as a novel therapeutic target to inhibit neuroinflammation and apoptosis after neonatal ischemic brain damage (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23376684
Anti-inflammatory effects of Cannabinoid 2 Receptor activation in endotoxin-induced uveitis (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24308861
Endocannabinoids: a unique opportunity to develop multitarget analgesics (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23623250
Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine inflammatory pain model (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24384256
Sending multiple sclerosis up in smoke (news – 2013) http://www.eurekalert.org/pub_releases/2013-10/afot-sms100713.php
5 Health Benefits Of Cannabichromene (CBC) (news – 2013) http://www.leafscience.com/2013/09/21/5-health-benefits-of-cannabichromene-cbc/
New Study: THC May Treat Inflammatory Diseases and Cancer By Altering Genes (news – 2013) http://thejointblog.com/new-study-thc-may-treat-inflammatory-diseases-cancer-altering-genes/
top
Marijuana’s Memory Paradox (news/ forum repost – 2013) http://ehealthforum.com/health/interesting-t164409.html
The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells (full – 2014) http://www.jbc.org/content/early/2014/03/18/jbc.M113.536953.long
Anandamide Attenuates Th-17 Cell-Mediated Delayed-Type Hypersensitivity Response by Triggering IL-10 Production and Consequent microRNA Induction (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974854/
Inhibition of Fatty Acid binding proteins elevates brain anandamide levels and produces analgesia (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976407/
A new face of endocannabinoids in pharmacotherapy. Part II. Role of endocannabinoids in inflammation-derived cardiovascular diseases (full – 2014) http://www.jpp.krakow.pl/journal/archive/04_14/pdf/183_04_14_article.pdf
Cannabinoid-induced autophagy regulates suppressor of cytokine signaling (SOCS)-3 in intestinal epithelium (full – 2014) http://ajpgi.physiology.org/content/307/2/G140
CB2 Receptor Activation Ameliorates the Proinflammatory Activity in Acute Lung Injury Induced by Paraquat (full – 2014) http://www.hindawi.com/journals/bmri/2014/971750/
Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes (full – 2014) http://www.jci.org/articles/view/64628
Activation of GPR40 attenuates chronic inflammation induced impact on pancreatic β-cells health and function (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083038/
Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis (full – 2014) http://www.biomedcentral.com/1471-2474/15/275
Endocannabinoids and inflammatory response in periodontal ligament cells (full – 2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0107407
Protective effects of cannabidiol on lesion-induced intervertebral disc degeneration (full – 2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0113161
Celastrol Attenuates Inflammatory and Neuropathic Pain Mediated by Cannabinoid Receptor Type 2 (full– 2014) http://www.mdpi.com/1422-0067/15/8/13637/htm
The endocannabinoid system: an emerging key player in inflammation. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24419242
Trans-Caryophyllene Suppresses Hypoxia-Induced Neuroinflammatory Responses by Inhibiting NF-κB Activation in Microglia (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24488604
Endocannabinoid 2-Arachidonylglycerol Protects Primary Cultured Neurons Against LPS-Induced Impairments in Rat Caudate Nucleus (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24510751
Endocannabinoids affect innate immunity of Muller glia during HIV-1 Tat cytotoxicity (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24418364
Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24529123
Evaluation of selective cannabinoid CB1 and CB2 receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24561047
Host Neuro- Immuno-Endocrine Responses In Periodontal Disease (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24588827
top
Role of the Endocannabinoid System in the Neuroendocrine Responses to Inflammation (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24588819
Cannabidiol enhances microglial phagocytosis via transient receptor potential (TRP) channel activation (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24641282
Therapeutical Potential of CB2 Receptors in Immune-Related Diseases (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24720538
Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24742657
Cannabinoid 1 receptors in keratinocytes attenuate FITC-induced mouse atopic-like dermatitis (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24750433
Cannabinoid type 2 receptor stimulation attenuates brain edema by reducing cerebral leukocyte infiltration following subarachnoid hemorrhage in rats (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24819918
Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24836296
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24854329
Role of Endocannabinoid Activation of Peripheral CB1 Receptors in the Regulation of Autoimmune Disease (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24911431
Anti-atherosclerosis role of N-oleoylethanolamine in CB2 (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24961101
Cannabinoid receptor activation inhibits cell cycle progression by modulating 14-3-3β (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25002257
Endocannabinoid 2-Arachidonylglycerol Protects Primary Cultured Neurons Against Homocysteine-Induced Impairments in Rat Caudate Nucleus Through CB1 Receptor (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25007951
Cannabinoid Receptor-2 and HIV-Associated Neurocognitive Disorders (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25015040
Cannabinoid receptor CB2 prevents development of heart failure in a murine model of pressure overload (abst – 2014) http://www.freedomwares.ca/p80cannabinoid-receptor-cb2-prevents-development-heart-failure-murine-model-pressure-overload/
Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damage (abst – 2014) http://onlinelibrary.wiley.com/doi/10.1002/jnr.23452/abstract
Increased oxidative stress enhances endocannabinoid tone (abst – 2014) http://www.fasebj.org/content/28/1_Supplement/671.13.abstract?sid=db987fd0-3ef0-4796-aff6-4103f0c84daf
Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25058512
Peripheral neurobiologic mechanisms of antiallodynic effect of warm water immersion therapy on persistent inflammatory pain (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25079058
The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24644287
Cannabis-Based Medicine Reduces Multiple Pathological Processes in AβPP/PS1 Mice (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25125475
top
Palmitoylethanolamide, a naturally-occurring lipid, is an orally effective intestinal anti-inflammatory agent (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25205418
Cannabinoid receptor type 2 activation in atherosclerosis and acute cardiovascular diseases (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25245379
Tapping into the endocannabinoid system to ameliorate acute inflammatory flares and associated pain in mouse knee joints (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25260980
Cannabinoids Alleviate Experimentally Induced Intestinal Inflammation by Acting at Central and Peripheral Receptors (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25275313
Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25273317
Molecular Basis for the Improvement in Muscle Metaboreflex and Mechanoreflex Control in Exercise-Trained Humans with Chronic Heart Failure (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25305179
The differential characterization of GPR55 receptor in human peripheral blood reveals a distinctive expression in monocytes and NK cells and a proinflammatory role in these innate cells (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25344934
Chronic administration of Δ9-tetrahydrocannabinol induces intestinal anti-inflammatory microRNA expression during acute SIV infection of rhesus macaques (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25378491
N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N palmitoylethanolamine levels and counteracts murine colitis (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25384424
Cannabinoid receptor type-2 stimulation, blockade, and deletion alters the vascular inflammatory responses to traumatic brain injury (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25416141
Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathways (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25413674
Mn-SOD Upregulation by Electroacupuncture Attenuates Ischemic Oxidative Damage via CB1R-Mediated STAT3 Phosphorylation (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25432886
Δ9 Tetrahydrocannabinol attenuates Staphylococcal enterotoxin B-induced inflammatory lung injury and prevents mortality in mice by modulation of miR-17-92 cluster and induction of T-regulatory cells (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25425209
Protective effect of palmitoylethanolamide, a naturally-occurring molecule, in a rat model of cystitis (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25463999
Neuroinflammation as a possible link between cannabinoids and addiction (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25455257
The Activated Endocannabinoid System in Atherosclerosis: Driving Force or Protective Mechanism? (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25469884
Cannabis smoking and serum C-reactive protein: A quantile regressions approach based on NHANES 2005–2010 (abst-2014) http://www.drugandalcoholdependence.com/article/S0376-8716%2814%2901929-2/abstract?cc=y
Potential applications of marijuana and cannabinoids in medicine (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25518584
COX-2-derived endocannabinoid metabolites as novel inflammatory mediators (abst-2014) http://www.cell.com/trends/pharmacological-sciences/abstract/S0165-6147%2814%2900035-2
top
Enhanced microglial activity in FAAH-/- animals (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25534441
Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer’s disease (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25210802
Neuroprotection by association of palmitoylethanolamide with luteolin in experimental Alzheimer’s disease models: the control of neuroinflammation (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25106636
Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25537576
Treatment with a Heme Oxygenase 1 Inducer Enhances the Antinociceptive Effects of µ-Opioid, δ-Opioid, and Cannabinoid 2 Receptors during Inflammatory Pain (abst – 2014) http://jpet.aspetjournals.org/content/351/1/224.abstract?sid=2e19342d-ea3a-4616-b131-905bea766ce9
Palmitoylethanolamide inhibits rMCP-5 expression by regulating MITF activation in rat chronic granulomatous inflammation (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24440533
Drugs Related to Cannabis Have Pain-Relieving Potential for Osteoarthritis (news – 2014) http://www.sciencedaily.com/releases/2014/01/140107092825.htm
Study uncovers marijuana’s potential to treat autoimmune diseases (news – 2014) http://www.news-medical.net/news/20140603/Study-uncovers-marijuanas-potential-to-treat-autoimmune-diseases.aspx
Synthetic cannabinoid molecule created for osteoarthritis (news – 2014) http://www.news-medical.net/news/20140107/Synthetic-cannabinoid-molecule-created-for-osteoarthritis.aspx
Pot Smokers Show Less Inflammation (news – 2014) http://news.yahoo.com/pot-smokers-show-less-inflammation-150518763.html
The spinal anti-inflammatory mechanism of motor cortex stimulation: cause of success and refractoriness in neuropathic pain? (full – 2015) http://www.jneuroinflammation.com/content/pdf/s12974-014-0216-1.pdf
Cannabinoid Receptor CB2 Is Involved in Tetrahydrocannabinol-Induced Anti-Inflammation against Lipopolysaccharide in MG-63 Cells (full – 2015) http://www.hindawi.com/journals/mi/2015/362126/
Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo (full – 2015) http://onlinelibrary.wiley.com/doi/10.1002/glia.22742/full
Activation of cannabinoid receptor 2 attenuates synovitis and joint distruction in collagen-induced arthritis (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25601571
Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25601726
Tonic Modulation of Nociceptive Behavior and Allodynia by Cannabinoid Receptors in Formalin Test in Rats (full – 2015) http://www.cps.org.tw/files/201503160252300.pdf
Monoacylglycerol lipase inhibitor JZL184 reduces neuroinflammatory response in APdE9 mice and in adult mouse glial cells. (full – 2015) http://www.jneuroinflammation.com/content/12/1/81
Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function. (full – 2015) http://link.springer.com/article/10.1007/s11481-015-9615-z/fulltext.html
top
Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells. (full – 2015) http://onlinelibrary.wiley.com/doi/10.1111/apha.12474/full
Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells. (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363052/
New horizons for newborn brain protection: enhancing endogenous neuroprotection (full – 2015) http://fn.bmj.com/content/early/2015/06/10/archdischild-2014-306284.long
Cannabinoid CB2 Receptors in a Mouse Model of Aβ Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of
Neuroinflammation. (full – 2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0129618
Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures (full–2015) http://www.hindawi.com/journals/np/2015/130639/
CB2R orchestrates fibrogenesis through regulation of inflammatory response during the repair of skeletal muscle contusion (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466920/
Activation of Cannabinoid Type Two Receptors (CB2) Diminish Inflammatory Responses in Macrophages and Brain Endothelium (full–2015) http://tinyurl.com/pv5snej
Effects of Cannabinoids on T-cell Function and Resistance to Infection (full – 2015) http://tinyurl.com/oqjfy9j
Time-Dependent Protection of CB2 Receptor Agonist in Stroke. (full – 2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0132487
Differential immune mechanism to HIV-1 Tat variants and its regulation by AEA (full – 2015) http://www.nature.com/srep/2015/150505/srep09887/full/srep09887.html
Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25537576
Δ9 Tetrahydrocannabinol attenuates Staphylococcal enterotoxin B-induced inflammatory lung injury and prevents mortality in mice by modulation of miR-17-92 cluster and induction of T-regulatory cells (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25425209
Activation of cannabinoid receptor 2 attenuates synovitis and joint distruction in collagen-induced arthritis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25601571
Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25601726
Magnolol inhibits the inflammatory response in mouse mammary epithelial cells and a mouse mastitis model (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25173887
Activation of murine microglial N9 cells is attenuated through cannabinoid receptor CB2 signaling (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25637536
Cannabidiol (CBD) and its analogs: a review of their effects on inflammation (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25703248
For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disorders. (abst – 2015) http://www.sciencedirect.com/science/article/pii/S027858461500055X
The endocannabinoid system and its therapeutic implications in rheumatoid arthritis (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25791728
Distribution of Bioactive Lipid Mediators in Human Skin. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25668241
top
Minocycline Attenuates Neonatal Germinal-Matrix-Hemorrhage-Induced Neuroinflammation and Brain Edema by Activating Cannabinoid Receptor 2 (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25833102
Potential of the cannabinoid CB2 receptor as a pharmacological target against inflammation in Parkinson’s disease. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25863279
Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoylglycerol and arachidonoyl-ethanolamide, and their metabolites. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25877930
The effect of FAAH, MAGL, and Dual FAAH/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in Rodents. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25869205
Differential upregulation of the cannabinoid CB2 receptor in neurotoxic and inflammation-driven rat models of Parkinson’s disease. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25895887
The monoacylglycerol lipase inhibitor JZL184 decreases inflammatory response in skeletal muscle contusion in rats. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25912803
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25935384
The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe? (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25936364
Downstream effects of endocannabinoid on blood cells: implications for health and disease. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25957591
Lipopolysaccharide-induced murine embryonic resorption involves changes in endocannabinoid profiling and alters progesterone secretion and inflammatory response by a CB1-mediated fashion. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25958042
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26055231
Involvement of cannabinoid receptors in infrasonic noise-induced neuronal impairment (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26058582
Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26189763
Topical cannabinoid receptor 1 agonist attenuates the cutaneous inflammatory responses in oxazolone-induced atopic dermatitis model (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26095080
Impact of a synthetic cannabinoid (CP-47,497-C8) on protein expression in human cells: evidence for induction of inflammation and DNA damage. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26194647
Fever Is Mediated by Conversion of Endocannabinoid 2-Arachidonoylglycerol to Prostaglandin E2 (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26196692
Circulating endocannabinoids during hematopoietic stem cell transplantation: A pilot study (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26114153
Endogenous 2-Arachidonoylglycerol Alleviates Cyclooxygenases-2 Elevation-Mediated Neuronal Injury from SO2 Inhalation via PPARγ Pathway (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26209559
top
Dietary DHA reduced downstream endocannabinoid and inflammatory gene expression, epididymal fat mass, and improved aspects of glucose use in muscle in C57BL/6J mice (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26219414
Novel Triazolopyrimidine-Derived Cannabinoid Receptor 2 Agonists As Potential Treatment for Inflammatory Kidney Diseases. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26228928


INTERACTIONS WITH OTHER DRUGS
THC Prevents MDMA Neurotoxicity in Mice (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824821/
Attenuation of morphine antinociceptive tolerance by a CB(1) receptor agonist and an NMDA receptor antagonist: Interactive effects. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2813317/?toolubmed
Adolescent cannabis use increases risk for cocaine-induced paranoia (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821949/pdf/nihms156770.pdf
Opioid antagonism enhances marijuana’s effects in heavy marijuana smokers. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2923559/pdf/nihms201310.pdf
Influence of ethanol on cannabinoid pharmacokinetic parameters in chronic users (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/21116612
Methamphetamine neurotoxicity increases brain expression and alters behavioral functions of CB₁ cannabinoid receptors. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20378129
The safety of modafinil in combination with oral Δ9-tetrahydrocannabinol in humans (abst – 2010) http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T0N-51S0WM1-1&_user=10&_coverDate=12%2F21%2F2010&_rdoc=1&_fmt=high&_orig=search&_origin=search&_sort=d&_docanchor=&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=a35b5a1c810b0d18a28df6a605746310&searchtype=a
Probable Interaction Between Warfarin and Marijuana Smoking (abst–2010) http://www.unboundmedicine.com/medline/ebm/record/19531696/abstract/Probable_Interaction_Between_Warfarin_and_Marijuana_Smoking__July/August__
The analgesic potential of cannabinoids (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20073408
Chocolate: The Good, the Bad and the Angry (news–2010) http://www.psychologytoday.com/blog/your-brain-food/201011/chocolate-the-good-the-bad-and-the-angry
Cocoa and the Search for Dietary Cannabinoids (news–2010) http://www.examiner.com/article/cocoa-and-the-search-for-dietary-cannabinoids
Cannabis-enhancing plant to be marketed worldwide as new drug (news – 2010) http://www.mnn.com/health/fitness-well-being/stories/cannabis-enhancing-plant-to-be-marketedworldwide-as-new-drug
Cannabidiol Attenuates Cisplatin-Induced Nephrotoxicity by Decreasing Oxidative/Nitrosative Stress, Inflammation, and Cell Death (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682269/
Acute effects of MDMA (3,4-methylenedioxymethamphetamine) on EEG oscillations: alone and in combination with ethanol or THC (delta-9-tetrahydrocannabinol) (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033515/?toolmcentrez
Inhibition of monoacylglycerol lipase (MAGL) attenuates NSAID-induced gastric hemorrhages in mice (full–2011) http://jpet.aspetjournals.org/content/early/2011/06/09/jpet.110.175778.long
top
Pretreatment with Δ9-tetrahydrocannabinol (THC) increases cocaine-stimulated activity in adolescent but not adult male rats (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242894/pdf/nihms328208.pdf
Combined effects of THC and caffeine on working memory in rats (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423236/
Clozapine and SCH 23390 prevent the spatial working memory disruption induced by Δ9-THC administration into the medial prefrontal cortex (full–2011) http://www.sciencedirect.com/science/article/pii/S0006899311001533
Cannabinoid system and cyclooxygenases inhibitors (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056416/?toolubmed
Previous exposure to delta9-tetrahydrocannibinol enhances locomotor responding to but not self-administration of amphetamine (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101004/pdf/zpt724.pdf
Combined effects of acute, very-low-dose ethanol and delta(9)-tetrahydrocannabinol in healthy human volunteers (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018238/
Possible involvement of the endocannabinoid system in memory modulation effect of general anesthetics (abst-2011) http://www.unboundmedicine.com/medline/ebm/record/21555187/abstract/Possible_involvement_of_the_endocannabinoid_system_in_memory_modulation_effect_of_general_anesthetics_
Role of GLT-1 transporter activation in prevention of cannabinoid tolerance by the betalactam antibiotic, ceftriaxone, in mice (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21536061/abstract/Role_of_GLT_1_transporter_activation_in_prevention_of_cannabinoid_tolerance_by_the_beta_lactam_antibiotic_ceftriaxone_in_mice_
Cannabis in Palliative Medicine: Improving Care and Reducing Opioid-Related Morbidity (abst-2011) http://ajh.sagepub.com/content/28/5/297
Cannabinoid-opioid interaction in chronic pain (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/22048225/abstract/Cannabinoid_opioid_interaction_in_chronic_pain_
A combined preclinical therapy of cannabinoids and temozolomide against glioma (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21220494
The safety of modafinil in combination with oral Δ9-tetrahydrocannabinol in humans (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21176784
Cannabidiol potentiates Δ(9)-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21667074
The G protein-coupled cannabinoid-1 (CB(1)) receptor of mammalian brain: Inhibition by phthalate esters in vitro (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21763743
The interplay of cannabinoid and NMDA glutamate receptor systems in humans: preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21062637/abstract/The_interplay_of_cannabinoid_and_NMDA_glutamate_receptor_systems_in_humans:_preliminary_evidence_of_interactive_effects_of_cannabidiol_and_ketamine_in_healthy_human_subjects_
Chronic administration of THC prevents the behavioral effects of intermittent adolescent MDMA administration and attenuates MDMA-induced hyperthermia and neurotoxicity in rats (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21763331
THC-methadone and THC-naltrexone interactions on discrimination, antinociception, and locomotion in rats. (abst-2011) http://www.unboundmedicine.com/medline/ebm/record/21716095/abstract/THC_methadone_and_THC_naltrexone_interactions_on_discrimination_antinociception_and_locomotion_in_rats_
Pharmacokinetics of a combination of Δ9-tetrahydro-cannabinol and celecoxib in a porcine model of hemorrhagic shock. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21341278/abstract/Pharmacokinetics_of_a_combination_of_%CE%949_tetrahydro_cannabinol_and_celecoxib_in_a_porcine_model_of_hemorrhagic_shock_
top
Low-volume binary drug therapy for the treatment of hypovolemia (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21330941/abstract/Low_volume_binary_drug_therapy_for_the_treatment_of_hypovolemia_
Efavirenz interference in urine screening immunoassays for tetrahydrocannabinol (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22067092
Pharmaceutical Drug-Herb Interaction List (news–2011) http://targetedcannabinoidtherapy.com/pharmaceutical-drug-herb-interaction-list
What Causes False Positives in Marijuana Drug Testing? (news – 2011) http://www.livestrong.com/article/192876-what-causes-false-positives-in-marijuana-drugtesting/#ixzz21IdMdpfG
Synergistic interaction of pregabalin with the synthetic cannabinoid WIN 55,212-2 mesylate in the hot-plate test in mice: an isobolographic analysis (full–2012) http://www.if-pan.krakow.pl/pjp/pdf/2012/3_723.pdf
Changes of Blood Endocannabinoids during Anaesthesia: a Special Case for Fatty Acid Amide Hydrolase Inhibition by Propofol? (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394128/
Effects of amphetamine on dopamine release in the rat nucleus accumbens shell region depend on cannabinoid CB1 receptor activation. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22426202
Effect of ACEA-a selective cannabinoid CB1 receptor agonist on the protective action of different antiepileptic drugs in the mouse pentylenetetrazole-induced seizure model. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22789660
Effects of dronabinol on morphine-induced dopamine-related behavioral effects in animals (abst – 2012) http://onlinelibrary.wiley.com/doi/10.1002/syn.21586/abstract
Cannabis as an adjunct to or substitute for opiates in the treatment of chronic pain (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22880540
Cannabidiol inhibits the reward-facilitating effect of morphine: involvement of 5-HT(1A) receptors in the dorsal raphe nucleus (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22862835
The periaqueductal gray contributes to bidirectional enhancement of antinociception between morphine and cannabinoids (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959123/
Effects of ethanol, Δ(9)-tetrahydrocannabinol, or their combination on object recognition memory and object preference in adolescent and adult male rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3477605/
Cannabinoids May Help Prevent MDMA induced brain damage (news–2012) http://www.examiner.com/article/cannabinoids-may-help-prevent-mdma-induced-brain-damage
Interactions between mu opioid receptor agonists and cannabinoid receptor agonists in rhesus monkeys: antinociception, drug discrimination, and drug self-administration (full–2013) http://jpet.aspetjournals.org/content/early/2013/03/27/jpet.113.204099.long
Treatment failure of intrathecal baclofen and supra-additive effect of nabiximols in multiple sclerosis-related spasticity: a case report (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625014/
A Phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of Rifampicin, Ketoconazole, and Omeprazole on the pharmacokinetics of THC/CBD oromucosal spray in healthy volunteers (full–2013) http://www.springerplus.com/content/2/1/236
Dual Inhibition of Endocannabinoid Catabolic Enzymes Produces Enhanced Anti-Withdrawal Effects in Morphine-Dependent Mice. (full – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23303065
Dissociation of the Pharmacological Effects of THC by mTOR Blockade (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656376/

AM281, Cannabinoid Antagonist/Inverse agonist, Ameliorates Scopolamine-Induced Cognitive Deficit (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586915/
top
Single doses of THC and cocaine decrease proficiency of impulse control in heavy cannabis users (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12425/full
In vitro metabolism and metabolic effects of ajulemic acid, a synthetic cannabinoid agonist (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/prp2.17/full
Prior Exposure to THC Increases the Addictive Effects of Nicotine in Rats. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656362/
Efavirenz does not cause false-positive urine cannabis test in HIV-infected patients on Highly Active Anti-Retroviral Therapy. (full – 2013) http://www.e-mjm.org/2013/v68n3/Efavirenz.pdf
Interactions between mu opioid receptor agonists and cannabinoid receptor agonists CP55940 and WIN55212-2 in rhesus monkeys: evaluation of treatment- and abuse related effects (abst – 2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/1097.3?sid=7a3e6978-9a8c-4319-bca1-9f80fed2445f
Role of intra-accumbal cannabinoid CB1 receptors in the potentiation, acquisition and expression of morphine-induced conditioned place preference (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23523958
Does olanzapine inhibit the psychomimetic effects of Δ9-tetrahydrocannabinol? (abst – 2013) http://jop.sagepub.com/content/26/10/1307.abstract
Acute Psychosis Associated with Recreational Use of Benzofuran 6-(2-Aminopropyl)Benzofuran (6-APB) and Cannabis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23733714
Acute Δ9-tetrahydrocannabinol blocks gastric hemorrhages induced by the nonsteroidal anti-inflammatory drug diclofenac sodium in mice (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23769745
Impact of Cannabis Use during Stabilization on Methadone Maintenance Treatment (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23795873
Additive antiemetic efficacy of low-doses of the cannabinoid CB1/2 receptor agonist Δ9-THC with ultralow-doses of the vanilloid TRPV1 receptor agonist resiniferatoxin in the least shrew (Cryptotis parva) (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24157976
Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24160757
The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2 (abst–2013) http://onlinelibrary.wiley.com/doi/10.1002/ijc.28591/abstract
Activation of type-2 cannabinoid receptor inhibits neuroprotective and antiinflammatory actions of glucocorticoid receptor α: when one is better than two. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23296125
Is Marijuana Medicinal? (news–2013) http://www.rheumatologynews.com/index.php?id=8821&cHash=071010&tx_ttnews%5Btt_news%5D=127219
Effects of WIN 55,212-2 (a non-selective cannabinoid CB1 and CB 2 receptor agonist) on the protective action of various classical antiepileptic drugs in the mouse 6 Hz psychomotor seizure model (full–2014) http://download.springer.com/static/pdf/828/art%253A10.1007%252Fs00702-014-1173-7.pdf?auth66=1393191519_d7b51017bd9f9b481c18158f0312786b&ext=.pdf
Cyclosporine and Herbal Supplement Interactions (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913293/
Updates on the Clinical Evidenced Herb-Warfarin Interactions (full–2014) http://www.hindawi.com/journals/ecam/2014/957362/

Δ9-tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity (full–2014) http://www.plosone.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0098079&representationDF
Combining rimonabant and fentanyl in a single entity: preparation and pharmacological results (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934591/
Pregnenolone can protect the brain from cannabis intoxication (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057431/
top
Acute administration of Δ9 tetrahydrocannabinol does not prevent enhancement of sensory gating by clozapine in DBA/2 mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24418217
Δ9-THC exposure attenuates aversive effects and reveals appetitive effects of K2/’Spice’ constituent JWH-018 in mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24625557
Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24709540
Anandamide attenuates haloperidol-induced vacuous chewing movements in rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24747871
Cannabis Withdrawal in Patients With and Without Opioid Dependence (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24745656
Cannabinoids negatively modulate striatal glutamate and dopamine release and behavioural output of acute d-amphetamine (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24867330
Analgesic tolerance and cross-tolerance to the cannabinoid receptors ligands hemopressin, VD-hemopressin(α and WIN55,212-2 at the supraspinal level in mice. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25010019
Effects of opioids and cannabinoids during chronic morphine treatment in rhesus monkeys (abst–2014) http://www.fasebj.org/content/28/1_Supplement/658.3.abstract?sid=467bb529-0ecc-4ddc-af27-3f56f520a102
Hormone shows promise at negating marijuana’s high effect (news – 2014) http://www.cbsnews.com/news/hormone-shows-promise-at-negating-marijuanas-high-effect/
Muting Marijuana’s High: Pot Without the Impairment (news – 2014) http://healthland.time.com/2014/01/03/muting-marijuanas-high-pot-without-the-impairment/
Alcohol and drugs put teens at increased risk for unsafe driving (news – 2014) http://www.news-medical.net/news/20140428/Alcohol-and-drugs-put-teens-at-increased-risk-for-unsafedriving.aspx
Medical marijuana laws may reduce painkiller overdoses (news – 2014) http://www.cnn.com/2014/08/25/health/medical-marijuana-overdose-deaths/index.html
States With Medical Marijuana Laws Have Fewer Opioid Overdose Deaths (news – 2014) http://time.com/3175582/states-with-medical-marijuana-laws-have-fewer-opioid-overdose-deaths/
How Black Pepper relieves Cannabis Anxiety (news – 2014) http://cannabisdigest.ca/black-pepper-relieves-cannabis-anxiety/
Novel associations between FAAH genetic variants and postoperative central opioid related adverse effects (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25558980
Effects of WIN 55,212-2 (a synthetic cannabinoid CB1 and CB2 receptor agonist) on the anticonvulsant activity of various novel antiepileptic drugs against 6 Hz-induced psychomotor seizures in mice (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25592741
Use of Prescription Pain Medications Among Medical Cannabis Patients: Comparisons of Pain Levels, Functioning, and Patterns of Alcohol and Other Drug Use (full–2015) http://ssw.umich.edu/sites/default/files/documents/news/use-of-prescription-pain-medications-amongmedical-cannabis-patients.pdf
Controlled Cannabis Vaporizer Administration: Blood and Plasma Cannabinoids with and without Alcohol (full–2015) http://www.clinchem.org/content/61/6/850.long
Interaction between Cannabinoid Compounds and Capsazepine in Protection against Acute Pentylenetetrazole-induced Seizure in Mice (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499434/
top
Novel associations between FAAH genetic variants and postoperative central opioidrelated adverse effects (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25558980
13-Year-Old Girl With Recurrent, Episodic, Persistent Vomiting: Out of the Pot and Into the Fire (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25733759
Anaesthetic consideration in a cannabis addict (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25933451
Cannabidiol effects in the prepulse inhibition disruption induced by amphetamine (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25943166
Cigarette smoking may modify the association between cannabis use and adiposity in males (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26026899
Morphine-induced locomotor sensitization produces structural plasticity in the mesocorticolimbic system dependent on CB1-R activity (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26179931
The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26187456
Cross-tolerance to cannabinoids in morphine-tolerant rhesus monkeys (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26202613
Do Cannabinoid Receptor Agonists Have A Role In The Intensive Care Unit? … Totally Dude! (abst–2015) http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A1657
Controlled vaporized cannabis, with and without alcohol: subjective effects and oral fluid-blood cannabinoid relationships (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26257143
Substance abuse risk not greater in those using medical marijuana with prescribed opioids (news–2015) http://www.eurekalert.org/pub_releases/2015-05/joso-sar051115.php


ISAACS’ SYNDROME/ACQUIRED NEUROMYOTONIA
Dramatic improvement of refractory Isaacs’ syndrome after treatment with dronabinol (full-2010) http://www.onlinepot.org/medical/IsaacsSyndrom.htm
Isaacs’ syndrome (forum post/anecdotal-2011) http://www.mdjunction.com/forums/isaacs-syndrome-discussions/general-support/2582654-isaacssyndrome


IQ/MEMORY/COGNITIVE EFFECTS
Influence of cannabis use trajectories, grade repetition and family background on the school-dropout rate at the age of 17 years in France (full-2010) http://eurpub.oxfordjournals.org/content/20/2/157.long
Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829220/?toolubmed
Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2906112/
Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study. (full – 2010) http://bjp.rcpsych.org/content/197/4/285.long
top
Evaluating the effect of aquatic extraction of Cannabis sativa seed on spatial memory consolidation (abst – 2010) http://www.annals-general-psychiatry.com/content/9/S1/S143
Evaluating the effect of Cannabis sativa seed extraction on memory (abst – 2010) http://www.annals-general-psychiatry.com/content/9/S1/S208
Inhibitory effect of ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on memory impairment and neuronal toxicity induced by beta-amyloid (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20004682
Gender moderates the impact of stereotype threat on cognitive function in cannabis users. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20483199
Key ingredient staves off marijuana memory loss (news – 2010) http://www.nature.com/news/2010/101001/full/news.2010.508.html?s=news_rss
Marijuana May Offset Alcohol-Induced Cognitive Impairment Among Teens (news – 2010) http://www.norml.org/index.cfm?Group_ID=8378
Are Stoners Really Dumb, or Do They Just Think They Are? (news – 2010) http://healthland.time.com/2010/11/18/are-stoners-really-dumb-or-do-they-just-think-they-are/
AM251, cannabinoids receptors ligand, improves recognition memory in rats. (full – 2011) http://www.if-pan.krakow.pl/pjp/pdf/2011/3_670.pdf
HIV-1 infection and alcohol abuse: neurocognitive impairment, mechanisms of neurodegeneration and therapeutic interventions. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098312/
Combined effects of THC and caffeine on working memory in rats. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423236/
Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045517/
Sex, drugs, and cognition: effects of marijuana. (full– 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3089380/?toolubmed
Clozapine and SCH 23390 prevent the spatial working memory disruption induced by Δ9-THC administration into the medial prefrontal cortex (full–2011) http://www.sciencedirect.com/science/article/pii/S0006899311001533
Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057300/
Intelligence across childhood in relation to illegal drug use in adulthood: 1970 British Cohort Study (full – 2011) http://www.academia.edu/1090026/Intelligence_across_childhood_in_relation_to_illegal_drug_use_in_adulthood_1970_British_Cohort_Study
Sexually dimorphic effects of cannabinoid compounds on emotion and cognition. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181427/pdf/fnbeh-05-00064.pdf
Effects of endocannabinoid system modulation on cognitive and emotional behavior. (full – 2011) http://journal.frontiersin.org/Journal/10.3389/fnbeh.2011.00057/full
Pharmacological elevation of anandamide impairs short-term memory by altering the neurophysiology in the hippocampus. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3156972/
Endocannabinoid signaling in the amygdala: anatomy, synaptic signaling, behavior, and adaptations to stress. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236282/
The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3156975/
Fish oil promotes survival and protects against cognitive decline in severely undernourished mice by normalizing satiety signals. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117120/
top
Effects of Chronic Marijuana Use on Brain Activity During Monetary Decision-Making (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260974/
Patent WO 2010012506 A1 – CANNABINOIDS FOR USE IN TREATING OR PREVENTING COGNITIVE IMPAIRMENT AND DEMENTIA (full-2011) http://www.google.it/patents/WO2010012506A1?cl=en
Possible involvement of the endocannabinoid system in memory modulation effect of general anesthetics (abst-2011) http://www.unboundmedicine.com/medline/ebm/record/21555187/abstract/Possible_involvement_of_the_endocannabinoid_system_in_memory_modulation_effect_of_general_anesthetics_
Early onset of aging-like changes is restricted to cognitive abilities and skin structure in Cnr1(-/-) mice. (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/20724033
Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being. (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21798112
Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders. (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21870037
4-O-Methylhonokiol attenuates memory impairment in presenilin 2 mutant mice through reduction of oxidative damage and inactivation of astrocytes and the ERK pathway. (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/20974250
Study: Marijuana Not Linked With Long Term Cognitive Impairment (news – 2011) http://healthland.time.com/2011/07/19/study-marijuana-not-linked-with-long-term-cognitive-impairment/
“Stoner Stupid” Myth Goes Up In Smoke (news – 2011) http://blog.norml.org/2011/07/27/stonet-stupid-myth-goes-up-in-smoke/
Are smart kids more likely to use drugs? (news – 2011) http://news.yahoo.com/smart-kids-more-likely-drugs-160000571.html
High Childhood IQ Linked to Subsequent Illicit Drug Use, Research Suggests (news–2011) http://www.sciencedaily.com/releases/2011/11/111114221018.htm
Cannabinoid-1 Receptor Protects The Brain From Aging (news – 2011) http://www.medicalnewstoday.com/releases/230948.php
Bodyguard for the brain (news–2011) http://www.sciencecodex.com/bodyguard_for_the_brain
Assessing topographical orientation skills in cannabis users (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259701/?toolubmed
Loss of CB1 receptors leads to differential age-related changes in reward-driven learning and memory. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514639/
Extinction learning of rewards in the rat: is there a role for CB1 receptors? (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161161/
Can the benefits of cannabinoid receptor stimulation on neuroinflammation, neurogenesis and memory during normal aging be useful in AD prevention? (full – 2012) http://www.jneuroinflammation.com/content/9/1/10
Intelligence quotient in childhood and the risk of illegal drug use in middle-age: the 1958 National Child Development Survey. (full – 2012) http://www.annalsofepidemiology.org/article/S1047-2797%2812%2900170-6/fulltext
The endocannabinoid system: a key modulator of emotions and cognition (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3490098/
Endocannabinoids in nervous system health and disease: the big picture in a nutshell (full – 2012) http://rstb.royalsocietypublishing.org/content/367/1607/3193.full
Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids (full-2012) http://rstb.royalsocietypublishing.org/content/367/1607/3254.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
top
Involvement of the endocannabinoid system in reward processing in the human brain (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266503/
Cannabis Responsive Head Injury Induced Mutiple Disabilities: A Case Report (full – 2012) http://file.scirp.org/Html/9-2500130_16958.htm
The endocannabinoid, anandamide, augments Notch-1 signaling in cultured cortical neurons exposed to amyloid-β and in the cortex of aged rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464574/
Dose-Related Modulation of Event-Related Potentials to Novel and Target Stimuli by Intravenous Δ(9)-THC in Humans. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358754/
Adolescent Exposure of JWH-018 “Spice” Produces Subtle Effects on Learning and Memory Performance in Adulthood (full – 2012) http://file.scirp.org/Html/2-3900080_19505.htm
The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546149/
Cannabinoids and value-based decision making: implications for neurodegenerative disorders (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496267/
Functional connectivity in brain networks underlying cognitive control in chronic cannabis users (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376324/
Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis (full – 2012) http://www.sciencedirect.com/science/article/pii/S0014299912008485
Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD. (full – 2012) http://www.sciencedirect.com/science/article/pii/S0092867412001420
Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuroinflammation, amyloidogenesis and memory impairment via inhibition of nuclear factor-kappaB in vitro and in vivo models. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323460/
Effects of ethanol, Δ(9)-tetrahydrocannabinol, or their combination on object recognition memory and object preference in adolescent and adult male rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3477605/
4-O-methylhonokiol prevents memory impairment in the Tg2576 transgenic mice model of Alzheimer’s disease via regulation of β-secretase activity. (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22330831?dopt=Abstract&holding=f1000,f1000m,isrctn
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23042808
Fear relief-toward a new conceptual frame work and what endocannabinoids gotta do with it. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22173015
Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional Features, and Emerging Specificities of the Two Major Endocannabinoids (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22801993
Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22260337
Cannabinoid CB1 receptor deficiency increases contextual fear memory under highly aversive conditions and long-term potentiation in vivo (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22579951
top
Neurocognitive functioning and cannabis use in schizophrenia. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22716156
Pharmacological effects of cannabinoids on the reference and working memory functions in mice (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22903389
Long-term behavioral and biochemical effects of an ultra-low dose of Δ(9)-tetrahydrocannabinol (THC): neuroprotection and ERK signaling (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22821081
Teen Marijuana Use May Show No Effect On Brain Tissue, Unlike Alcohol, Study Finds (news–2012) http://www.huffingtonpost.com/2012/12/21/teens-marijuana-brain-tissue-alcohol_n_2331779.html
Pot smoking not tied to middle-age mental decline (news – 2012) http://www.mnn.com/health/fitness-well-being/stories/pot-smoking-not-tied-to-middle-age-mental-decline
Structured Unlearning: Marijuana May Impair Memory via the Brain’s Non-Firing Cells (news – 2012) http://news.yahoo.com/structured-unlearning-marijuana-may-impair-memory-via-brains-170000064.html
Michael Pollan: What Do Marijuana and Catnip Have in Common? (news–2012) http://www.alternet.org/drugs/148510/michael_pollan:_what_do_marijuana_and_catnip_have_in_common/
Does Cannabis Boost Creativity? (news – 2012) http://www.wakingtimes.com/2012/03/14/does-cannabis-boost-creativity/
A biophysical model of endocannabinoid-mediated short term depression in hippocampal inhibition. (full – 2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0058926
Working memory- and anxiety-related behavioral effects of repeated nicotine as a stressor: the role of cannabinoid receptors (full – 2013) http://www.biomedcentral.com/content/pdf/1471-2202-14-20.pdf
Modulation of the Endocannabinoids N-Arachidonoylethanolamine (AEA) and 2- Arachidonoylglycerol (2-AG) on Executive Functions in Humans (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0066387
Single doses of THC and cocaine decrease proficiency of impulse control in heavy cannabis users. (full – 2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12425/full
Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877004/
An investigation into “two hit” effects of BDNF deficiency and young-adult cannabinoid receptor stimulation on prepulse inhibition regulation and memory in mice. (full – 2013) http://www.frontiersin.org/Journal/10.3389/fnbeh.2013.00149/full
Effects of magnolol on impairment of learning and memory abilities induced by scopolamine in mice. (full – 2013) https/www.jstage.jst.go.jp/article/bpb/36/5/36_b12-00880/_html
Correlations between cannabis use and IQ change in the Dunedin cohort are consistent with confounding from socioeconomic status. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600466/
A role for the endocannabinoid system in exercise-induced spatial memory enhancement in mice. (full – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24115292
Inhibition of FAAH and activation of PPAR: New approaches to the treatment of cognitive dysfunction and drug addiction (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662489/
COMT val158met and 5-HTTLPR genetic polymorphisms moderate executive control in cannabis users (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682154/
top
AM281, Cannabinoid Antagonist/Inverse agonist, Ameliorates Scopolamine-Induced Cognitive Deficit. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586915/
Cannabinoids ameliorate impairments induced by chronic stress to synaptic plasticity and short-term memory. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682147/
Novelty-Induced Emotional Arousal Modulates Cannabinoid Effects on Recognition Memory and Adrenocortical Activity (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656371/
Dissociation of the Pharmacological Effects of THC by mTOR Blockade. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656376/
Activation of the CB(2) receptor system reverses amyloid-induced memory deficiency. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/22795792
Developmentally-induced hypothyroidism alters the expression of Egr-1 and Arc genes and the sensitivity to cannabinoid agonists in the hippocampus. Possible implications for memory and learning. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23079472
Cannabidiol attenuates deficits of visuo-spatial associative memory induced by Δ9 tetrahydrocannabinol (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23550724
CB1 receptor signaling regulates social anxiety and memory (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23647582
Effect of cannabinoid CB2 receptor agonism on learning and memory in a mouse model of photothrombosis (abst–2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/1097.4?sid=eea722c0-971c-4daa-8b8c-38c0c63c19ad
Cannabidiol attenuates the long lasting cognitive deficits and anxiogenic-like behaviors promoted by murine cerebral malaria (abst–2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/1097.9?sid=eea722c0-971c-4daa-8b8c-38c0c63c19ad
Synaptic plasticity alterations associated with memory impairment induced by deletion of CB2 cannabinoid receptors. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23796670
Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer’s disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23838176
Cannabis abuse is associated with better emotional memory in schizophrenia: A functional magnetic resonance imaging study. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23906663
Impact of ADHD and cannabis use on executive functioning in young adults. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23992650
Effects of a novel CB1 agonist on visual attention in male rats: Role of strategy and expectancy in task accuracy. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24099361
CB1 Receptor-Mediated Signaling Underlies the Hippocampal Synaptic, Learning and Memory Deficits Following Treatment with JWH-081, a New Component of Spice/K2 Preparations. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24123667
Differential effects of the cannabinoid agonist WIN55,212-2 on delay and trace eyeblink conditioning (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24128358
Performance in working memory and attentional control is associated with the rs2180619 SNP in the CNR1 gene. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24152087
Impulsivity, Variation in the Cannabinoid Receptor (CNR1) and Fatty Acid Amide Hydrolase (FAAH) Genes, and Marijuana-Related Problems. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24172113
Cannabidiol Normalizes Capase 3, Synatophsin, and Mitochondrial Fission Protein DNM1L Expression Levels in Rats with Brain Iron Overload: Implications for Neuroprotection (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23893294
top
Endocannabinoids underlie reconsolidation of hedonic memories in Wistar rats. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24247477
Relationship between working-memory network function and substance use: a 3-year longitudinal fMRI study in heavy cannabis users and controls (abst–2013) http://onlinelibrary.wiley.com/doi/10.1111/adb.12111/abstractThe endocannabinoid system: An emotional buffer in the modulation of memory function (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24382324
Link between pot smoking and IQ drop challenged (news – 2013) http://news.yahoo.com/between-pot-smoking-iq-drop-challenged-205231682.html
Low Doses of THC (Cannabis) Can Halt Brain Damage, Study Suggests (news – 2013) http://www.sciencedaily.com/releases/2013/05/130530132531.htm
Marijuana may improve stamina, rejuvenate brain—study (news–2013) http://ph.news.yahoo.com/marijuana-may-improve-stamina-rejuvenate-brain-study-133517268.html
New Study Shows Cannabinoids Improve Efficiency Of Mitochondria And Remove Damaged Brain Cells (news–2013) http://www.collective-evolution.com/2013/05/30/new-study-shows-cannabinoids-improve-efficiency-ofmitochondria-and-remove-damaged-brain-cells/
New Study: Cannabinoids Protect the Brain and Heart From Injury (news – 2013) http://www.science20.com/news_articles/thc_can_prevent_brain_damage_study-113512
In Mice Anti-Inflammatories Ameliorate Medical Marijuana’s Memory Mishaps (news–2013) http://news.yahoo.com/mice-anti-inflammatories-ameliorate-medical-marijuanas-memory-mishaps-165808519.html
Science for potheads: Why they love to get high (news–2013) http://www.salon.com/2013/09/08/science_for_potheads_why_they_love_to_get_high/
Marijuana’s Memory Paradox (news/forum repost–2013) http://ehealthforum.com/health/interesting-t164409.html
The effect of AM281, a cannabinoid antagonist, on memory performance during spontaneous morphine withdrawal in mice (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895301/
Chronic ethanol alters network activity and endocannabinoid signaling in the prefrontal cortex (full–2014) http://journal.frontiersin.org/Journal/10.3389/fnint.2014.00058/full
Reductions in Endocannabinoid Levels and Enhanced Coupling of Cannabinoid Receptors in the Striatum are Accompanied by Cognitive Impairments in the AβPPswe/PS1ΔE9 Mouse Model of Alzheimer’s Disease (full-2014) http://iospress.metapress.com/content/0617070q2404258h/?genre=article&id=doi%3a10.3233%2fJAD-131961
Impaired Fear Memory Specificity Associated with Deficient Endocannabinoid-Dependent Long-Term Plasticity (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24457285
Relationship between working-memory network function and substance use: a 3-year longitudinal fMRI study in heavy cannabis users and controls (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24589297
Neurocognition in college-aged daily marijuana users (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24620756
Elevation of Endogenous Anandamide Impairs LTP, Learning and Memory through CB1 Receptor Signaling in Mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24648181
Acute administration of THC impairs spatial but not associative memory function in zebrafish (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24639045
Cognitive performance and peripheral endocannabinoid system receptor expression in schizophrenia (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24853061
top
WIN55212-2 impairs non-associative, recognition and spatial memory in rats via CB1 receptor stimulation (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24867078
β-Amyloid Inhibits E-S Potentiation through Suppression of Cannabinoid Receptor 1-Dependent Synaptic Disinhibition (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24945775
CB1 receptor antagonism in the granular insular cortex or somatosensory area facilitates consolidation of object recognition memory (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25004406
Cannabinoid Receptor-2 and HIV-Associated Neurocognitive Disorders (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25015040
Reductions in Endocannabinoid Levels and Enhanced Coupling of Cannabinoid Receptors in the Striatum are Accompanied by Cognitive Impairments in the AβPPswe/PS1ΔE9 Mouse Model of Alzheimer’s Disease (abst–2014) http://iospress.metapress.com/content/0617070q2404258h/?p=e36fa00480454cc9ae10e6351455c445&pi=4
Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damage (abst–2014) http://onlinelibrary.wiley.com/doi/10.1002/jnr.23452/abstract
Impact of Stress on Prefrontal Glutamatergic, Monoaminergic and Cannabinoid Systems (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25048388
Fatty Acid-binding Protein 5 (FABP5) Regulates Cognitive Function Both by Decreasing Anandamide Levels and by Activating the Nuclear Receptor Peroxisome Proliferatoractivated Receptor β/δ (PPARβ/δ in the Brain (abst–2014) http://www.jbc.org/content/289/18/12748.abstract?sid=58027e04-8d1d-47c5-b6d3-49611e578de4
Cannabis-Based Medicine Reduces Multiple Pathological Processes in AβPP/PS1 Mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25125475
Pot-smoking students better at school than ‘marginalized’ tobacco-smoking peers (news–2014) http://www.ctvnews.ca/health/pot-smoking-students-better-at-school-than-marginalized-tobacco-smokingpeers-1.1745098#ixzz2x6Iq4iMr
Marijuana Users Have Better Cognitive Skills, Study Finds (news–2014) http://www.leafscience.com/2014/03/14/marijuana-users-better-cognitive-skills-study-finds/
Marijuana: Occasional Cannabis Use in Teenagers Has ‘No Relationship’ with IQ or Exam Results (news–2014) https://uk.news.yahoo.com/marijuana-occasional-cannabis-teenagers-no-relationship-iq-exam-131850613.html#baXFolW
No, marijuana use doesn’t lower your IQ (news–2014) http://www.washingtonpost.com/blogs/wonkblog/wp/2014/10/22/no-marijuana-use-doesnt-lower-your-iq/
Augmented Inhibition from Cannabinoid-Sensitive Interneurons Diminishes CA1 Output after Traumatic Brain Injury (full–2015) http://journal.frontiersin.org/Journal/10.3389/fncel.2014.00435/full
Motor, Visual and Emotional Deficits in Mice after Closed-Head Mild Traumatic Brain Injury Are Alleviated by the Novel CB2 Inverse Agonist SMM-189 (full–2015) http://www.mdpi.com/1422-0067/16/1/758/htm
Cannabis conundrum: Evidence of harm?: Opposition to marijuana use is often rooted in arguments about the drug’s harm to children and adults, but the scientific evidence is seldom clear-cut (article–2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21516/full
Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25560837
Cannabidiol increases survival and promotes rescue of cognitive function in a murine model of Cerebral Malaria (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25595981
top
Modulation of the effects of the cannabinoid agonist, ACPA, on spatial and non-spatial novelty detection in mice by dopamine D1 receptor drugs infused into the basolateral amygdala (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25476564
How Medical Marijuana’s Chemicals May Protect Cells (news–2015) http://www.scientificamerican.com/article/how-medical-marijuana-s-chemicals-may-protect-cells/

Augmented Inhibition from Cannabinoid-Sensitive Interneurons Diminishes CA1 Output after Traumatic Brain Injury (full–2015) http://journal.frontiersin.org/Journal/10.3389/fncel.2014.00435/full
Motor, Visual and Emotional Deficits in Mice after Closed-Head Mild Traumatic Brain Injury Are Alleviated by the Novel CB2 Inverse Agonist SMM-189 (full–2015) http://www.mdpi.com/1422-0067/16/1/758/htm
Cannabis conundrum: Evidence of harm?: Opposition to marijuana use is often rooted in arguments about the drug’s harm to children and adults, but the scientific evidence is seldom clear-cut (article–2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21516/full
Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25560837
Cannabidiol increases survival and promotes rescue of cognitive function in a murine model of Cerebral Malaria (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25595981
Modulation of the effects of the cannabinoid agonist, ACPA, on spatial and non-spatial novelty detection in mice by dopamine D1 receptor drugs infused into the basolateral amygdala (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25476564
How Medical Marijuana’s Chemicals May Protect Cells (news–2015) http://www.scientificamerican.com/article/how-medical-marijuana-s-chemicals-may-protect-cells/
Changes in cannabinoid receptors, aquaporin 4 and vimentin expression after traumatic brain injury in adolescent male mice. Association with edema and neurological deficit (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0128782
Defects in fatty acid amide hydrolase 2 in a male with neurologic and psychiatric symptoms (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423390/
Effects of high-fructose diets on central appetite signaling and cognitive function (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429636/
Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284516/
Task-specific enhancement of hippocampus-dependent learning in mice deficient in monoacylglycerol lipase, the major hydrolyzing enzyme of the endocannabinoid 2-arachidonoylglycerol (full–2015) http://journal.frontiersin.org/article/10.3389/fnbeh.2015.00134/full
Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors (full–2015) http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002194
Hormonal status and age differentially affect tolerance to the disruptive effects of delta-9-tetrahydrocannabinol (Δ(9)-THC) on learning in female rats. (full – 2015) http://journal.frontiersin.org/article/10.3389/fphar.2015.00133/full
Cannabis and psychopathology: The meandering journey of the last decade (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462782/
Homeostatic regulation of brain functions by endocannabinoid signaling (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468750/
Cannabis conundrum: Evidence of harm?: Opposition to marijuana use is often rooted in arguments about the drug’s harm to children and adults, but the scientific evidence is seldom clear-cut (article–2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21516/full
top
Cannabidiol increases survival and promotes rescue of cognitive function in a murine model of Cerebral Malaria (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25595981
Modulation of the effects of the cannabinoid agonist, ACPA, on spatial and non-spatial novelty detection in mice by dopamine D1 receptor drugs infused into the basolateral amygdala (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25476564
Involvement of the serotonergic system of the ventral hippocampus (CA3) on amnesia induced by ACPA in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25771207
Effects of cannabinoid and glutamate receptor antagonists and their interactions on learning and memory in male rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25684318
Intraperirhinal cortex administration of the synthetic cannabinoid, HU210, disrupts object recognition memory in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25714419
The potential of inhibitors of endocannabinoid metabolism as anxiolytic and antidepressive drugs-A practical view (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25791296
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 suppress chronic cerebral hypoperfusion-induced neuronal apoptosis by inhibiting c-Jun N-terminal kinase signaling (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25795598
Effects of URB597 as an inhibitor of fatty acid amide hydrolase on WIN55, 212-2-induced learning and memory deficits in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25689415
Cognitive performance in a placebo-controlled pharmacotherapy trial for youth with marijuana dependence (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25661990
The effects of chronic marijuana use on circadian entrainment (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25801606
The dual effect of CA1 NMDA receptor modulation on ACPA-induced amnesia in stepdown passive avoidance learning task (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25680309
Neuropsychological sex differences associated with age of initiated use among young adult cannabis users (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25832823
The interactive role of cannabinoid and vanilloid systems in hippocampal synaptic plasticity in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25843413
Cannabinoid functions in the amygdala contribute to conditioned fear memory in streptozotocin-induced diabetic mice: interaction with glutamatergic functions (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25929688
Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25960036
The endocannabinoid system and associative learning and memory in zebrafish (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25956869
Cluster of Acute Toxicity from Ingestion of Synthetic Cannabinoid-Laced Brownies (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25967137
Astroglial type-1 cannabinoid receptors (CB1): A new player in the tripartite synapse (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25967266
Endocannabinoid-mediated improvement on a test of aversive memory in a mouse model of fragile X syndrome (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25979787
A selective cannabinoid CB2 agonist attenuates damage and improves memory retention following stroke in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26032254
top
Involvement of cannabinoid receptors in infrasonic noise-induced neuronal impairment (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26058582
Role of the endocannabinoid system in the emotional manifestations of osteoarthritis pain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26067584
The influence of cannabinoids on learning and memory processes of the dorsal striatum (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26092091
Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio). (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26099242
Inhibition of fatty-acid amide hydrolyse (FAAH) exerts cognitive improvements in male but not female rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26238495
No additive effect of cannabis on cognition in schizophrenia (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26235754
How Medical Marijuana’s Chemicals May Protect Cells (news–2015) http://www.scientificamerican.com/article/how-medical-marijuana-s-chemicals-may-protect-cells/
Daily pot use not associated with brain shrinkage: Colorado study (news–2015) http://news.yahoo.com/daily-pot-not-associated-brain-shrinkage-colorado-study-235549441.html
Cannabis: World-renowned researchers discuss a new frontier in therapeutics (news–2015) http://medicalxpress.com/news/2015-02-cannabis-world-renowned-discuss-frontier-therapeutics.html